CHURCH & DWIGHT CO INC /DE/, 10-Q filed on 5/1/2026
Quarterly Report
v3.26.1
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2026
Apr. 29, 2026
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2026  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Trading Symbol CHD  
Entity Registrant Name CHURCH & DWIGHT CO., INC.  
Entity Central Index Key 0000313927  
Current Fiscal Year End Date --12-31  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity File Number 1-10585  
Entity Tax Identification Number 13-4996950  
Entity Address, Address Line One 500 Charles Ewing Boulevard  
Entity Address, City or Town Ewing  
Entity Address, State or Province NJ  
Entity Address, Postal Zip Code 08628  
City Area Code 609  
Local Phone Number 806-1200  
Entity Incorporation, State or Country Code DE  
Title of 12(b) Security Common Stock, $1 par value  
Security Exchange Name NYSE  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Entity Common Stock, Shares Outstanding   236,943,602
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Net Sales $ 1,469.3 $ 1,467.1
Cost of sales 787.9 807.5
Gross Profit 681.4 659.6
Marketing expenses 139.4 136.6
Selling, general and administrative expenses 251.0 227.7
Income from Operations 291.0 295.3
Equity in earnings of affiliates 2.3 1.6
Interest income 2.5 9.3
Interest expense (24.0) (23.3)
Other income (expense), net 0.8 (0.8)
Income before Income Taxes 272.6 282.1
Income taxes 56.3 62.0
Net Income $ 216.3 $ 220.1
Weighted average shares outstanding - Basic 236.5 245.8
Weighted average shares outstanding - Diluted 238.1 248.0
Net income per share - Basic $ 0.91 $ 0.9
Net income per share - Diluted 0.91 0.89
Cash dividends per share $ 0.31 $ 0.29
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Comprehensive Income [Abstract]    
Net income $ 216.3 $ 220.1
Other comprehensive income, net of tax:    
Foreign exchange translation adjustments (4.5) 6.3
Defined benefit plan adjustments gain (loss) (0.4) 0.4
Income (loss) from derivative agreements 8.2 (1.9)
Other comprehensive income 3.3 4.8
Comprehensive income $ 219.6 $ 224.9
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Current Assets    
Cash and cash equivalents $ 503.4 $ 409.0
Accounts receivable, less allowances of $3.8 and $3.7 576.6 593.4
Inventories 578.4 534.8
Other current assets 62.3 59.8
Total Current Assets 1,720.7 1,597.0
Property, Plant and Equipment, Net 823.9 822.8
Equity Investment in Affiliates 12.3 10.3
Trade Names and Other Intangibles, Net 3,477.2 3,511.5
Goodwill 2,629.4 2,627.5
Other Assets 343.0 343.3
Total Assets 9,006.5 8,912.4
Current Liabilities    
Accounts payable 729.9 732.4
Accrued expenses and other liabilities 452.7 583.0
Business acquisition and divestiture liabilities 197.2 178.9
Income taxes payable 33.6 3.4
Total Current Liabilities 1,413.4 1,497.7
Long-term Debt 2,205.7 2,205.1
Deferred Income Taxes 891.6 886.9
Deferred and Other Long-term Liabilities 309.8 320.5
Total Liabilities 4,820.5 4,910.2
Commitments and Contingencies
Stockholders' Equity    
Preferred Stock, $1.00 par value, Authorized 2,500,000 shares; none issued 0.0 0.0
Common Stock, $1.00 par value, Authorized 600,000,000 shares and 293,709,982 shares issued as of March 31, 2026 and December 31, 2025 293.7 293.7
Additional paid-in capital 654.1 625.1
Retained earnings 6,911.5 6,768.2
Accumulated other comprehensive loss (16.6) (19.9)
Common stock in treasury, at cost: 56,818,945 shares as of March 31, 2026 and 57,156,105 shares as of December 31, 2025 (3,656.7) (3,664.9)
Total Stockholders' Equity 4,186.0 4,002.2
Total Liabilities and Stockholders' Equity $ 9,006.5 $ 8,912.4
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Statement of Financial Position [Abstract]    
Accounts receivable, allowances $ 3.8 $ 3.7
Preferred Stock, par value $ 1.00 $ 1.00
Preferred Stock, Authorized 2,500,000 2,500,000
Preferred Stock, issued 0 0
Common Stock, par value $ 1.00 $ 1.00
Common Stock, Authorized 600,000,000 600,000,000
Common Stock, shares issued 293,709,982 293,709,982
Common Stock in Treasury 56,818,945 57,156,105
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flow From Operating Activities    
Net Income (Loss) $ 216.3 $ 220.1
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation expense 21.6 22.6
Amortization expense 41.3 38.3
Deferred income taxes 4.5 (3.5)
Equity in net earnings of affiliates (2.3) (1.6)
Distributions from unconsolidated affiliates 0.2 1.8
Non-cash compensation expense 25.7 20.7
Asset impairment charge and other asset write-offs 1.7 1.4
Other (0.2) 0.1
Subtotal 308.8 299.9
Change in assets and liabilities:    
Accounts receivable 13.7 6.6
Inventories (45.1) (16.0)
Other current assets (8.3) (7.0)
Accounts payable 2.3 (7.8)
Accrued expenses (131.3) (141.5)
Income taxes payable 44.2 55.1
Other operating assets and liabilities, net (9.5) (3.6)
Change in Working Capital (134.0) (114.2)
Net Cash Provided By Operating Activities 174.8 185.7
Cash Flow From Investing Activities    
Additions to property, plant and equipment (31.9) (16.5)
Other (1.6) (0.2)
Net Cash Used In Investing Activities (33.5) (16.7)
Cash Flow From Financing Activities    
Proceeds from stock options exercised 16.6 19.3
Payment of cash dividends (72.9) (72.4)
Payment of business acquisition liability (19.8) (5.9)
Proceeds from VMS Transition Services Agreement 36.2 0.0
Other (5.0) (2.0)
Net Cash Used In Financing Activities (44.9) (61.0)
Effect of exchange rate changes on cash and cash equivalents (2.0) 2.4
Net Change In Cash and Cash Equivalents 94.4 110.4
Cash and Cash Equivalents at Beginning of Period 409.0 964.1
Cash and Cash Equivalents at End of Period 503.4 1,074.5
Cash paid during the period for:    
Interest (net of amounts capitalized) 15.3 14.9
Income taxes 7.2 10.3
Supplemental disclosure of non-cash investing activities:    
Property, plant and equipment expenditures included in Accounts Payable $ 14.4 $ 13.1
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common Stock [Member]
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2024 $ 4,360.8 $ 293.7 $ (2,784.8) $ 563.1 $ 6,319.7 $ (30.9)
Beginning Balance (in shares) at Dec. 31, 2024   293,700,000        
Beginning Balance (in shares) at Dec. 31, 2024     (47,800,000)      
Net income 220.1       220.1  
Other comprehensive income (loss) 4.8         4.8
Cash dividends (72.4)       (72.4)  
Stock based compensation expense and stock option plan transactions 37.7   $ 10.7 27.2 (0.2)  
Stock based compensation expense and stock option plan transactions (in shares)     300,000      
Ending Balance at Mar. 31, 2025 4,551.0 $ 293.7 $ (2,774.1) 590.3 6,467.2 (26.1)
Ending Balance (in shares) at Mar. 31, 2025   293,700,000        
Ending Balance (in shares) at Mar. 31, 2025     (47,500,000)      
Beginning Balance at Dec. 31, 2025 $ 4,002.2 $ 293.7 $ (3,664.9) 625.1 6,768.2 (19.9)
Beginning Balance (in shares) at Dec. 31, 2025   293,700,000        
Beginning Balance (in shares) at Dec. 31, 2025 57,156,105   (57,200,000)      
Net income $ 216.3       216.3  
Other comprehensive income (loss) 3.3         3.3
Cash dividends (72.9)       (72.9)  
Stock based compensation expense and stock option plan transactions 37.1   $ 8.2 29.0 (0.1)  
Stock based compensation expense and stock option plan transactions (in shares)     400,000      
Ending Balance at Mar. 31, 2026 $ 4,186.0 $ 293.7 $ (3,656.7) $ 654.1 $ 6,911.5 $ (16.6)
Ending Balance (in shares) at Mar. 31, 2026   293,700,000        
Ending Balance (in shares) at Mar. 31, 2026 56,818,945   (56,800,000)      
v3.26.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Pay vs Performance Disclosure    
Net Income (Loss) $ 216.3 $ 220.1
v3.26.1
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.26.1
Basis of Presentation
 3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Basis of Presentation
1.
Basis of Presentation

These condensed consolidated financial statements have been prepared by Church & Dwight Co., Inc. (the “Company”). In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position and results of operations and cash flows for all periods presented have been made. Results of operations for interim periods may not be representative of results expected for the full year.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 (the “Form 10-K”).

The Company incurred research and development expenses in the first quarter of 2026 and 2025 of $31.6 and $32.8, respectively. These expenses are included in selling, general and administrative (“SG&A”) expenses.
v3.26.1
New Accounting Pronouncements
 3 Months Ended
Mar. 31, 2026
Accounting Changes and Error Corrections [Abstract]  
New Accounting Pronouncements
2.
New Accounting Pronouncements

 

Recent Accounting Pronouncements Not Yet Adopted

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses and in January 2025, the FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date ("ASU 2025-01"). The ASU requires a public business entity to provide disaggregated disclosures of certain categories of expenses on an annual and interim basis including purchases of inventory, employee compensation, depreciation, and intangible asset amortization for each income statement line item that contains those expenses. ASU 2024-03, as clarified by ASU 2025-01, is effective for annual reporting periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with prospective or retrospective application permitted. The Company is currently evaluating the impact of adoption on the Company’s related disclosures.

There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.
v3.26.1
Inventories
 3 Months Ended
Mar. 31, 2026
Inventory Disclosure [Abstract]  
Inventories
3.
Inventories

Inventories consist of the following:

 

March 31,

 

 

December 31,

 

 

2026

 

 

2025

 

Raw materials and supplies

$

139.0

 

 

$

143.7

 

Work in process

 

24.0

 

 

 

35.0

 

Finished goods

 

415.4

 

 

 

356.1

 

Total

$

578.4

 

 

$

534.8

 
v3.26.1
Property, Plant and Equipment, Net ("PP&E")
 3 Months Ended
Mar. 31, 2026
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment, Net ("PP&E")
4.
Property, Plant and Equipment, Net (“PP&E”)

PP&E consists of the following:

 

March 31,

 

 

December 31,

 

 

2026

 

 

2025

 

Land

$

16.4

 

 

$

16.0

 

Buildings and improvements

 

368.6

 

 

 

367.5

 

Machinery and equipment

 

913.0

 

 

 

911.1

 

Software

 

139.2

 

 

 

138.9

 

Office equipment and other assets

 

131.4

 

 

 

131.6

 

Construction in progress

 

147.6

 

 

 

131.9

 

Gross PP&E

 

1,716.2

 

 

 

1,697.0

 

Less accumulated depreciation

 

892.3

 

 

 

874.2

 

Net PP&E

$

823.9

 

 

$

822.8

 

 

 

Three Months Ended

 

 

March 31,

 

 

March 31,

 

 

2026

 

 

2025

 

Depreciation expense on PP&E

$

21.6

 

 

$

22.6

 
v3.26.1
Earnings Per Share ("EPS")
 3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Earnings Per Share ("EPS")
5.
Earnings Per Share (“EPS”)

Basic EPS is calculated based on income available to holders of the Company’s common stock (“Common Stock”) and the weighted average number of shares outstanding during the reported period. Diluted EPS includes additional dilution from potential Common Stock issuable pursuant to the Company's stock-based compensation plans.

The following table sets forth a reconciliation of the weighted average number of shares of Common Stock outstanding to the weighted average number of shares outstanding on a diluted basis:

 

Three Months Ended

 

 

March 31,

 

 

March 31,

 

 

2026

 

 

2025

 

Weighted average common shares outstanding - basic

 

236.5

 

 

 

245.8

 

Dilutive effect of stock awards

 

1.6

 

 

 

2.2

 

Weighted average common shares outstanding - diluted

 

238.1

 

 

 

248.0

 

Antidilutive stock awards outstanding

 

3.1

 

 

 

2.1

 

 
v3.26.1
Stock Based Compensation Plans
 3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Stock Based Compensation Plans
6.
Stock Based Compensation Plans

The Company's Long-Term Incentive Program (“LTIP”) provides employees with an award of stock options and grants of restricted stock units (“RSUs”), and grants of performance share units ("PSUs"). Awards are granted in the first quarter of each year. The Company recognizes the grant-date fair value for each of these awards, less estimated forfeitures, as compensation expense ratably over the vesting period. For employees and directors that meet retirement eligibility requirements, the expense related to share-based compensation is recognized on the date of grant as there is no future service period required for the awards to vest.

 

Stock Options

The following table provides a summary of option activity:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

Weighted

 

 

Remaining

 

 

 

 

 

 

 

 

Average

 

 

Contractual

 

 

Aggregate

 

 

 

 

 

Exercise Price

 

 

Term

 

 

Intrinsic

 

 

Options

 

 

(per share)

 

 

(in Years)

 

 

Value

 

Outstanding at December 31, 2025

 

8.8

 

 

$

81.83

 

 

 

 

 

 

 

Granted

 

0.8

 

 

 

103.94

 

 

 

 

 

 

 

Exercised

 

(0.2

)

 

 

61.01

 

 

 

 

 

 

 

Outstanding at March 31, 2026

 

9.4

 

 

$

84.24

 

 

 

5.9

 

 

$

118.5

 

Exercisable at March 31, 2026

 

6.6

 

 

$

75.37

 

 

 

4.6

 

 

$

118.5

 

 

The following table provides information regarding the intrinsic value of stock options exercised and stock compensation expense related to stock option awards:

 

 

Three Months Ended

 

 

March 31,

 

 

March 31,

 

 

2026

 

 

2025

 

Intrinsic Value of Stock Options Exercised

$

9.6

 

 

$

16.3

 

Stock Compensation Expense Related to Stock Option Awards

$

9.2

 

 

$

13.1

 

Issued Stock Options

 

0.8

 

 

 

1.0

 

Weighted Average Fair Value of Stock Options issued (per share)

$

28.75

 

 

 

33.43

 

Fair Value of Stock Options Issued

$

24.0

 

 

 

32.3

 

 

The following table provides a summary of the assumptions used in the valuation of issued stock options:

 

 

Three Months Ended

 

March 31,

 

March 31,

 

2026

 

2025

Risk-free interest rate

3.8%

 

4.2%

Expected life in years

6.7

 

7.0

Expected volatility

22.5%

 

22.6%

Dividend yield

1.2%

 

1.1%

 

 

Restricted Stock Units

The annual RSU grants vest in one-third increments on each of the first, second and third anniversaries of the grant date, subject to the recipient’s continued employment with the Company from the grant date through the applicable vesting date, and are settled with shares of the Company’s Common Stock within 60 days following the applicable vesting date.

The following table provides a summary of RSU activity:

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

Weighted

 

 

Remaining

 

 

 

 

 

 

 

 

Average Grant

 

 

Contractual

 

 

Aggregate

 

 

 

 

 

Date Fair Value

 

 

Term

 

 

Intrinsic

 

 

Shares

 

 

(per award)

 

 

(in Years)

 

 

Value

 

Outstanding at December 31, 2025

 

0.3

 

 

$

100.40

 

 

 

 

 

 

 

Granted

 

0.1

 

 

 

101.44

 

 

 

 

 

 

 

Vested

 

(0.1

)

 

 

97.41

 

 

 

 

 

 

 

Outstanding at March 31, 2026

 

0.3

 

 

$

101.77

 

 

 

9.2

 

 

$

27.6

 

Vested and expected to vest at March 31, 2026

 

0.3

 

 

$

101.77

 

 

 

9.2

 

 

$

27.6

 

In connection with the Touchland Acquisition (as defined in Note 10), Touchland’s founder was granted rights to receive shares of our common stock valued at $50.0, with 50% of such shares vesting at each of the first and second year anniversaries of the closing. The value of common stock received by Touchland's founder will be recognized as a compensation expense ratably over the two-year vesting period if the individual continues to be employed by the Company. The restricted stock expense associated with the Touchland Acquisition for the three months ended March 31, 2026 was $6.3, and is included in the non-cash compensation expense caption in the Condensed Consolidated Statement of Cash Flows. Refer to Note 10-Acquisitions for additional details.

Performance Stock Units

Beginning in 2026, the Company expanded the annual PSU grant to a greater number of employees. The annual PSU grants are issued in two equal tranches. Each tranche has a different performance metric and grant date fair value. The performance metric for one tranche is based on the Company’s total shareholder return (“TSR”) relative to a Company-selected peer group and is valued using a Monte Carlo model. The performance metric for the second tranche is the Company's three-year cumulative cash flow from operations target and is valued using the Company's grant date closing stock value. The PSUs vest on the later of (i) the third anniversary of the grant date and (ii) the date that the Board's Compensation & Human Capital Committee certifies the achievement of the applicable performance goals, in each case, subject to the recipient’s continued employment with the Company from the grant date through the vesting date. The number of shares that may be issued ranges from 0% to 200% based on relative TSR and cumulative cash flow from operations during the three-year performance period.

In January 2026, the Company granted a 2030 long-term strategy grant of PSUs ( the "Strategy Grant") to Company employees at the director level and above, including the Company's executive officers. The PSU's awarded pursuant to the Strategy Grant will cliff vest following a four-year performance period, subject to the recipients remaining continuously employed for the full four-year performance period and satisfaction of the performance conditions. The PSU awards are tied to three equally weighted core long-term growth drivers (1) the Company’s net sales compound annual growth rate (“CAGR”) of the Arm & Hammer brand, (2) the net sales CAGR derived from sources outside of the United States and (3) the net sales CAGR derived from oral care products, including TheraBreath. The number of shares that may be issued ranges from 0% to 200% based on the performance of the long-term growth drivers over the four-year performance period.

The following table provides a summary of PSU activity:

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

Weighted

 

 

Remaining

 

 

 

 

 

 

 

 

Average Grant

 

 

Contractual

 

 

Aggregate

 

 

 

 

 

Date Fair Value

 

 

Term

 

 

Intrinsic

 

 

Shares

 

 

(per award)

 

 

(in Years)

 

 

Value

 

Outstanding at December 31, 2025

 

0.1

 

 

$

106.52

 

 

 

 

 

 

 

Granted

 

0.6

 

 

 

95.03

 

 

 

 

 

 

 

Outstanding at March 31, 2026

 

0.7

 

 

$

96.64

 

 

 

9.8

 

 

$

59.8

 

Vested and expected to vest at March 31, 2026

 

0.7

 

 

$

96.64

 

 

 

9.8

 

 

$

59.8

 

 

Employee Stock Purchase Plan

The Company’s Employee Stock Purchase Plan (“ESPP”) was adopted in February 2023 by the Company’s Board of Directors and became effective in April 2023 upon approval by the Company’s stockholders, and was most recently amended and restated

effective April 4, 2026. There are 750,000 shares of Common Stock reserved for issuance under the ESPP. The ESPP, which is intended to be an “employee stock purchase plan” under Section 423 of the Internal Revenue Code, permits eligible employees to purchase Common Stock through after-tax payroll deductions. Currently, the purchase price under the ESPP is 85% of the fair market value of our Common Stock on the last trading day of the applicable quarterly purchase period. The maximum value of Common Stock that an eligible employee may purchase each calendar year is the lesser of 10% of an eligible employee’s annual pay and $25,000. There are four purchase periods in each calendar year under the ESPP, which begin on the first business day of each calendar quarter and end on the last business day of each calendar quarter. The first purchase period commenced in January 2025. There are 728,031 Common Shares remaining as of March 31, 2026 that are reserved for issuance under the ESPP. As of December 31, 2025, there were 660,582 Common Shares reserved for issuance under the ESPP.
v3.26.1
Share Repurchases
 3 Months Ended
Mar. 31, 2026
Payments for Repurchase of Equity [Abstract]  
Share Repurchases
7.
Share Repurchases

On October 28, 2021, the Board authorized the Company’s share repurchase program, under which the Company may repurchase up to $1,000.0 in shares of Common Stock (the “2021 Share Repurchase Program”). The 2021 Share Repurchase Program does not have an expiration and replaced the 2017 Share Repurchase Program.

As of March 31, 2026, there remains $228.9 of share repurchase availability under the 2021 Share Repurchase Program.

The 2021 Share Repurchase Program did not modify the Company’s evergreen share repurchase program, authorized by the Board on January 29, 2014, under which the Company may repurchase, from time to time, Common Stock to reduce or eliminate dilution associated with issuances of Common Stock under its incentive plans.

v3.26.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Fair Value Measurements
8.
Fair Value Measurements

The following table presents the carrying amounts and estimated fair values of the Company’s other financial instruments at March 31, 2026 and December 31, 2025:

 

 

 

March 31, 2026

 

 

December 31, 2025

 

 

Input

 

Carrying

 

 

Fair

 

 

Carrying

 

 

Fair

 

 

Level

 

Amount

 

 

Value

 

 

Amount

 

 

Value

 

Financial Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

Level 1

 

$

291.8

 

 

$

291.8

 

 

$

217.5

 

 

$

217.5

 

Financial Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

3.15% Senior notes due August 1, 2027

Level 2

 

 

424.9

 

 

 

419.1

 

 

 

424.9

 

 

 

420.1

 

2.3% Senior notes due December 15, 2031

Level 2

 

 

399.5

 

 

 

354.6

 

 

 

399.5

 

 

 

355.4

 

5.6% Senior notes due November 15, 2032

Level 2

 

 

499.4

 

 

 

526.6

 

 

 

499.3

 

 

 

532.3

 

3.95% Senior notes due August 1, 2047

Level 2

 

 

397.9

 

 

 

313.2

 

 

 

397.9

 

 

 

318.4

 

5.00% Senior notes due June 15, 2052

Level 2

 

 

499.9

 

 

 

448.0

 

 

 

499.9

 

 

 

457.3

 

The Company recognizes transfers between input levels as of the actual date of the event. There were no transfers between input levels during the three months ended March 31, 2026 and 2025.

Refer to Note 2 in the Form 10-K for a description of the methods and assumptions used to estimate the fair value of each class of financial instruments reflected in the Condensed Consolidated Balance Sheets.

The carrying amounts of Accounts Receivable, Accounts Payable, and Accrued Expenses and Other Liabilities, approximated estimated fair values as of March 31, 2026 and December 31, 2025.

v3.26.1
Derivative Instruments and Risk Management
 3 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Risk Management
9.
Derivative Instruments and Risk Management

Changes in interest rates, foreign exchange rates, the price of the Company’s Common Stock and commodity prices expose the Company to market risk. The Company manages these risks by the use of derivative instruments, such as cash flow and fair value hedges, diesel and commodity hedge contracts, equity derivatives and foreign exchange forward contracts. The Company does not use derivatives for trading or speculative purposes. Refer to Note 3 in the Form 10-K for a discussion of each of the Company’s derivative instruments in effect as of December 31, 2025.

The notional amount of a derivative instrument is the nominal or face amount used to calculate payments made on that instrument. Notional amounts are presented in the following table:

 

 

Notional

 

 

Notional

 

 

 

Amount

 

 

Amount

 

 

 

March 31, 2026

 

 

December 31, 2025

 

Derivatives designated as hedging instruments

 

 

 

 

 

 

Foreign exchange contracts

 

$

391.2

 

 

$

438.2

 

Diesel fuel contracts

 

3.4 gallons

 

 

4.5 gallons

 

Commodities contracts

 

54.8 pounds

 

 

43.6 pounds

 

Net Investment hedge

 

$

25.0

 

 

$

25.0

 

Derivatives not designated as hedging instruments

 

 

 

 

 

 

Foreign exchange contracts

 

$

9.1

 

 

$

2.4

 

Equity derivatives

 

$

13.0

 

 

$

12.0

 

 

The fair values and amount of gain (loss) recognized in income and Other Comprehensive Income (“OCI”) associated with the derivative instruments disclosed above did not have a material impact on the Company’s condensed consolidated financial statements during the three months ended March 31, 2026.

v3.26.1
Acquisitions
 3 Months Ended
Mar. 31, 2026
Business Combination [Abstract]  
Acquisitions
10.
Acquisitions

On July 16, 2025, the Company completed the acquisition of Touchland Holding Corp ("Touchland"), the developer of TOUCHLAND® hand sanitizer products (the "Touchland Acquisition"). The Company paid $656.0, net of cash acquired, at closing and entered an agreement to pay an additional amount based on 2025 net sales thresholds which resulted in a cash payment of $158.7 in April 2026. In addition, the Company granted rights to Touchland’s founder to receive shares of our Common Stock valued at $50.0, with 50% of such shares vesting at each of the first- and -second-year anniversaries of the closing. The value of Common Stock received by Touchland's founder will be recognized as compensation expense ratably over the two-year vesting period if the individual continues to be employed by the Company. A payment of $5.0 of the purchase price was deferred related to certain indemnification obligations provided by Touchland’s equity holders, which amount, to the extent not used in satisfaction of such indemnity obligations, is payable three years from the closing. The Touchland Acquisition was financed with cash on hand and is managed in the Consumer Domestic and Consumer International segments. Touchland’s annual net sales for the year ended December 31, 2024 were approximately $115.0 million.

The preliminary fair values of the net assets at acquisition are set forth as follows:

 

Accounts receivable

$

9.3

 

Inventory

 

25.8

 

Other current assets

 

1.3

 

Property, plant and equipment

 

5.5

 

Other long-term assets

 

2.1

 

Trade name

 

730.0

 

Customer relationship intangible asset

 

32.8

 

Goodwill

 

208.4

 

Accounts payable, accrued expenses and other liabilities

 

(23.3

)

Business acquisition liabilities - short-term

 

(141.9

)

Deferred income taxes

 

(183.8

)

Deferred and other long-term liabilities

 

(10.2

)

Cash purchase price at closing (net of cash acquired)

$

656.0

 

The trade name and customer relationship intangible assets were valued using a discounted cash flow model and have a useful life of 20 years. The goodwill is a result of expected synergies from combined operations of the acquired business and the Company.

Pro forma results are not presented because the impact of the acquisition is not material to the Company’s consolidated financial results. The goodwill and other intangible assets associated with the Touchland Acquisition are not deductible for U.S. tax purposes.

 

11.
Divestitures and Business Exits

Spinbrush Divestiture

On May 1, 2025, the Company announced that it would exit the Spinbrush business which resulted in a pre-tax loss of $21.2, of which $12.6 was recorded in Cost of Sales and $8.6 was recorded in SG&A expenses. In December 2025, the Company entered into an agreement to transfer all Spinbrush intellectual property to a third party for nominal consideration. Net sales of the Spinbrush business were $53.6 in the year ended December 31, 2025.

Flawless Business Exit

On May 1, 2025, the Company announced that it would exit the Flawless business which resulted in a pre-tax loss of $17.6, of which $6.0 was recorded in Cost of Sales and $11.6 was recorded in SG&A expenses. We exited this business by the end of 2025. Net sales of the Flawless business were $29.3 in the year ended December 31, 2025.

Waterpik Showerheads Business Exit

On May 1, 2025, the Company announced that it would exit the Waterpik showerheads business which resulted in a pre-tax loss of $6.5 recorded in Cost of Sales. We exited this business by the end of 2025. Net sales of the Waterpik showerheads business were $35.5 in the year ended December 31, 2025.

VMS Divestiture

On December 9, 2025, the Company announced a definitive agreement to sell the VitaFusion and L’il Critters brands to Piping Rock Health Products, Inc. ("Piping Rock"). This agreement includes the VitaFusion and L’il Critters brands, relevant trademarks and licenses, and the Company's former manufacturing and distribution facilities in Vancouver and Ridgefield, Washington. The transaction closed on December 31, 2025 and includes a short-duration transition services agreement ("TSA"). The Company has a TSA-related liability of $36.2 as of March 31, 2026, primarily for net cash collected offset by invoices paid on behalf of Piping Rock.

In connection with the agreement, the Company derecognized PP&E of $142.9, inventory of $54.0, goodwill of $12.6 and other net assets including leases of $9.3 for net cash proceeds of $160.3. The VMS brands represented less than 5% of the Company’s 2025 net sales. As a result of this transaction, the Company incurred a pre-tax charge of $58.5 (post-tax of $45.6) in the fourth quarter of 2025 which was included in Other income (expense), net in the Consolidated Statements of Income.

The divestiture of the Company's VMS business does not meet the criteria to be reported as discontinued operations in the consolidated financial statements as the Company's decision to divest this business does not represent a strategic shift that will have a significant impact on the Company's operations and financial results.
v3.26.1
Divestitures and Business Exits
 3 Months Ended
Mar. 31, 2026
Discontinued Operations and Disposal Groups [Abstract]  
Disposal Groups Including Discontinued Operations Disclosure TextBlock
11.
Divestitures and Business Exits

Spinbrush Divestiture

On May 1, 2025, the Company announced that it would exit the Spinbrush business which resulted in a pre-tax loss of $21.2, of which $12.6 was recorded in Cost of Sales and $8.6 was recorded in SG&A expenses. In December 2025, the Company entered into an agreement to transfer all Spinbrush intellectual property to a third party for nominal consideration. Net sales of the Spinbrush business were $53.6 in the year ended December 31, 2025.

Flawless Business Exit

On May 1, 2025, the Company announced that it would exit the Flawless business which resulted in a pre-tax loss of $17.6, of which $6.0 was recorded in Cost of Sales and $11.6 was recorded in SG&A expenses. We exited this business by the end of 2025. Net sales of the Flawless business were $29.3 in the year ended December 31, 2025.

Waterpik Showerheads Business Exit

On May 1, 2025, the Company announced that it would exit the Waterpik showerheads business which resulted in a pre-tax loss of $6.5 recorded in Cost of Sales. We exited this business by the end of 2025. Net sales of the Waterpik showerheads business were $35.5 in the year ended December 31, 2025.

VMS Divestiture

On December 9, 2025, the Company announced a definitive agreement to sell the VitaFusion and L’il Critters brands to Piping Rock Health Products, Inc. ("Piping Rock"). This agreement includes the VitaFusion and L’il Critters brands, relevant trademarks and licenses, and the Company's former manufacturing and distribution facilities in Vancouver and Ridgefield, Washington. The transaction closed on December 31, 2025 and includes a short-duration transition services agreement ("TSA"). The Company has a TSA-related liability of $36.2 as of March 31, 2026, primarily for net cash collected offset by invoices paid on behalf of Piping Rock.

In connection with the agreement, the Company derecognized PP&E of $142.9, inventory of $54.0, goodwill of $12.6 and other net assets including leases of $9.3 for net cash proceeds of $160.3. The VMS brands represented less than 5% of the Company’s 2025 net sales. As a result of this transaction, the Company incurred a pre-tax charge of $58.5 (post-tax of $45.6) in the fourth quarter of 2025 which was included in Other income (expense), net in the Consolidated Statements of Income.

The divestiture of the Company's VMS business does not meet the criteria to be reported as discontinued operations in the consolidated financial statements as the Company's decision to divest this business does not represent a strategic shift that will have a significant impact on the Company's operations and financial results.
v3.26.1
Goodwill and Other Intangibles, Net
 3 Months Ended
Mar. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangibles, Net
12.
Goodwill and Other Intangibles, Net

The Company has intangible assets of substantial value on its Condensed Consolidated Balance Sheet. These intangible assets are generally related to intangible assets with a useful life, indefinite-lived trade names and goodwill. The Company determines whether an intangible asset (other than goodwill) has a useful life based on multiple factors, including how long the Company intends to generate cash flows from the asset. These intangible assets are more fully explained in the following sections.

 

Indefinite-Lived Intangible Assets

The following table presents the carrying value of indefinite-lived intangible assets:

 

March 31,

 

 

December 31,

 

 

2026

 

 

2025

 

Gross Carrying Value Trade Names

$

1,672.5

 

 

$

1,680.7

 

Sale of Spinbrush Tradename

 

0.0

 

 

 

(7.9

)

Trade Names

$

1,672.5

 

 

$

1,672.8

 

 

The Company’s indefinite-lived intangible impairment review is completed in the fourth quarter of each year.

Fair value for indefinite-lived intangible assets was estimated based on a “relief from royalty” or “excess earnings” discounted cash flow method, which contains numerous variables that are subject to change as business conditions change, and therefore could impact fair values in the future. The key assumptions used in determining fair value are sales growth, profitability margins, tax rates, discount rates and royalty rates.

On May 1, 2025, the Company announced that it would exit the Spinbrush business which resulted in a pre-tax loss of $21.2, of which $12.6 was recorded in Cost of Sales and $8.6 was recorded in SG&A expenses. In December 2025, the Company entered into an agreement to transfer all Spinbrush intellectual property to a third party for nominal consideration. Net sales of the Spinbrush business were $53.6 in the year ended December 31, 2025.

The Company’s global WATERPIK business is experiencing customer distribution losses and a decline in consumer demand, mainly due to lower consumer spending and more customers choosing value brands amid inflation. This has reduced sales, profits, and expected cash flows, eroding much of the excess fair value over carrying value for the WATERPIK trade name. As of October 1, 2025 (the date of the Company's last annual impairment test), the trade name’s carrying value was $644.7, with fair value at 117% of carrying value, down from 135% in 2024, reflecting declining sales, rising competition, business exits, and margin pressure from higher costs and tariffs. The Company's impairment analysis used an 8.0% discount rate, projected mid-single- to low double-digit revenue growth, and EBITA margins around 25%, based on current market trends and cost-lowering initiatives. Further declines in performance or adverse changes could trigger an impairment charge for the WATERPIK trade name.

Intangible Assets With a Useful Life

The following table provides information related to the carrying value of intangible assets with a useful life:

 

March 31, 2026

 

 

 

December 31, 2025

 

 

Gross

 

 

 

 

 

 

 

Amortization

 

Gross

 

 

 

 

 

 

 

 

 

 

 

Carrying

 

 

Accumulated

 

 

 

 

Period

 

Carrying

 

 

Accumulated

 

 

Impairment

 

 

 

 

 

Amount

 

 

Amortization

 

 

Net

 

(Years)

 

Amount

 

 

Amortization

 

 

Charges(1)

 

 

Net

 

Amortizable intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade Names

$

2,066.8

 

 

$

(551.8

)

 

$

1,515.0

 

3-20

 

$

2,113.4

 

 

$

(562.1

)

 

$

(11.6

)

 

$

1,539.7

 

Customer Relationships

 

573.3

 

 

 

(347.3

)

 

 

226.0

 

15-20

 

 

598.5

 

 

 

(365.2

)

 

 

(0.7

)

 

 

232.6

 

Patents/Formulas

 

200.7

 

 

 

(137.0

)

 

 

63.7

 

4-20

 

 

205.6

 

 

 

(139.2

)

 

 

0.0

 

 

 

66.4

 

Total

$

2,840.8

 

 

$

(1,036.1

)

 

$

1,804.7

 

 

 

$

2,917.5

 

 

$

(1,066.5

)

 

$

(12.3

)

 

$

1,838.7

 

 

(1) The $12.3 impairment charge relates to the Flawless trade name and Spinbrush customer relationship intangible asset, which had a gross value of $76.2 and accumulated amortization of $63.9 prior to full impairment. The impairments were a result of the Company's decision to exit these businesses.

Intangible amortization expense was $33.8 and $29.3 for the first quarter of 2026 and 2025, respectively. The Company estimates that intangible amortization expense will be approximately $135.0 in 2026 and approximately $134.0 declining to $120.0 annually over the next five years.

Goodwill

The carrying amount of goodwill is as follows:

 

Consumer

 

 

Consumer

 

 

Specialty

 

 

 

 

 

Domestic

 

 

International

 

 

Products

 

 

Total

 

Balance at December 31, 2025

$

2,255.4

 

 

$

237.2

 

 

$

134.9

 

 

$

2,627.5

 

Touchland Acquisition adjustments

 

1.9

 

 

 

0.0

 

 

 

0.0

 

 

 

1.9

 

Balance at March 31, 2026

$

2,257.3

 

 

$

237.2

 

 

$

134.9

 

 

$

2,629.4

 

 

The Company tests goodwill for each reporting unit, which are also the Company's reportable segments. The result of the Company’s annual goodwill impairment test, performed in the beginning of the second quarter of 2025, determined that the estimated fair value substantially exceeded the carrying values of all reporting units. The determination of fair value contains numerous variables that are subject to change as business conditions change and therefore could impact fair value in the future.
v3.26.1
Leases
 3 Months Ended
Mar. 31, 2026
Leases [Abstract]  
Leases
13.
Leases

The Company leases certain manufacturing facilities, warehouses, office space, railcars and equipment. Leases with an initial term of twelve months or less are not recorded on the Condensed Consolidated Balance Sheet. All recorded leases are classified as operating leases and lease expense is recognized on a straight-line basis over the lease term. Lease components (base rental costs) are accounted for separately from the nonlease components (e.g., common-area maintenance costs). For leases that do not provide an implicit rate, the Company uses its estimated secured incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

A summary of the Company’s lease information is as follows:

 

 

March 31,

 

December 31,

 

 

Classification

2026

 

2025

 

Assets

 

 

 

 

 

Right of use assets

Other Assets

$

159.7

 

$

166.0

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

Current lease liabilities

Accrued Expenses and Other Liabilities

$

24.6

 

$

23.9

 

Long-term lease liabilities

Deferred and Other Long-term Liabilities

 

147.1

 

 

153.0

 

Total lease liabilities

 

$

171.7

 

$

176.9

 

 

 

 

 

 

 

Other information

 

 

 

 

 

Weighted-average remaining lease term (years)

 

 

7.3

 

 

7.4

 

Weighted-average discount rate

 

 

5.2

%

 

5.2

%

 

 

 

Three Months

 

 

Three Months

 

 

Ended

 

 

Ended

 

 

March 31, 2026

 

 

March 31, 2025

 

Statement of Income

 

 

 

 

 

Lease cost(1)

$

8.8

 

 

$

10.5

 

 

 

 

 

 

 

Other information

 

 

 

 

 

Leased assets obtained in exchange for new lease liabilities net of modifications

$

0.4

 

 

$

6.5

 

Cash paid for amounts included in the measurement of lease liabilities

$

7.7

 

 

$

10.5

 
(1)
Lease expense is included in Cost of sales or SG&A expenses based on the nature of the leased item. Short-term lease expense is excluded from this amount and is not material. The Company also has certain variable leases which are not material. The non-cash component of lease expense for the first three months of 2026 and 2025 was $6.5 and $8.1, respectively, and is included in the Amortization caption in the Condensed Consolidated Statement of Cash Flows.

The Company’s minimum annual rentals including reasonably assured renewal options under lease agreements are as follows:

 

 

Operating

 

 

 

Leases

 

2026

 

$

24.7

 

2027

 

 

30.9

 

2028

 

 

26.7

 

2029

 

 

26.1

 

2030

 

 

25.8

 

2031 and thereafter

 

 

73.6

 

Total future minimum lease commitments

 

 

207.8

 

Less: Imputed interest

 

 

(36.1

)

Present value of lease liabilities

 

$

171.7

 

 
v3.26.1
Accounts Payable, Accrued and Other Liabilities
 3 Months Ended
Mar. 31, 2026
Payables and Accruals [Abstract]  
Accounts Payable, Accrued Expenses and Other Liabilities
14.
Accounts Payable, Accrued Expenses and Other Liabilities

Accounts payable, accrued expenses and other liabilities consist of the following:

 

March 31,

 

 

December 31,

 

 

2026

 

 

2025

 

Accounts payable

$

729.9

 

 

$

732.4

 

Accrued marketing and promotion costs

 

180.4

 

 

 

221.4

 

Accrued wages and related benefit costs

 

60.7

 

 

 

145.7

 

Other accrued current liabilities

 

408.8

 

 

 

394.8

 

Total

$

1,379.8

 

 

$

1,494.3

 

 

In 2015, the Company initiated a Supply Chain Finance program (“SCF Program”). Under the SCF Program, qualifying suppliers may elect to sell their receivables from the Company for early payment. Participating suppliers negotiate their receivables sales arrangements directly with a third party. The Company is not party to those agreements and do not have an economic interest in the suppliers' decisions to sell their receivables and has not been required to pledge any assets as security nor to provide any guarantee to third-party finance providers or intermediaries. The SCF Program may allow suppliers to obtain more favorable terms than they could secure on their own. The terms of the Company's payment obligations are not impacted by a supplier’s participation in the SCF Program. The Company's payment terms with suppliers are consistent between suppliers that elect to participate in the SCF Program and those that do not participate. As a result, the program does not have an impact to the Company's average days outstanding.

As of March 31, 2026 and December 31, 2025, the obligations outstanding related to the SCF program amounted to $115.9 and $84.7, respectively and were recorded within Accounts Payable in the Condensed Consolidated Balance Sheets. Payments included in operating activities within the Company's Condensed Consolidated Statements of Cash Flows amounted to $108.1 and $106.5 as of March 31, 2026 and 2025, respectively.
v3.26.1
Long-Term Debt
 3 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Long-Term Debt
15.
Long-Term Debt

Long-term debt consists of the following:

 

March 31,

 

 

December 31,

 

 

2026

 

 

2025

 

 

 

 

 

 

 

Long-term debt

 

 

 

 

 

3.15% Senior notes due August 1, 2027

$

425.0

 

 

$

425.0

 

Less: Discount

 

(0.1

)

 

 

(0.1

)

2.3% Senior notes due December 15, 2031

 

400.0

 

 

 

400.0

 

Less: Discount

 

(0.5

)

 

 

(0.5

)

5.6% Senior notes due November 15, 2032

 

500.0

 

 

 

500.0

 

Less: Discount

 

(0.6

)

 

 

(0.7

)

3.95% Senior notes due August 1, 2047

 

400.0

 

 

 

400.0

 

Less: Discount

 

(2.1

)

 

 

(2.1

)

5.00% Senior notes due June 15, 2052

 

500.0

 

 

 

500.0

 

Less: Discount

 

(0.1

)

 

 

(0.1

)

Debt issuance costs, net

 

(15.9

)

 

 

(16.4

)

Total long-term debt

$

2,205.7

 

 

$

2,205.1

 

 

 
v3.26.1
Accumulated Other Comprehensive Income (Loss)
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Accumulated Other Comprehensive Income (Loss)
16.
Accumulated Other Comprehensive Income (Loss)

The components of changes in accumulated other comprehensive income (loss) are as follows:

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

Foreign

 

 

Defined

 

 

 

 

 

Other

 

 

Currency

 

 

Benefit

 

 

Derivative

 

 

Comprehensive

 

 

Adjustments

 

 

Plans

 

 

Agreements

 

 

Income (Loss)

 

Balance at January 1, 2025

$

(53.2

)

 

$

4.4

 

 

$

17.9

 

 

$

(30.9

)

Other comprehensive income (loss) before reclassifications

 

6.3

 

 

 

0.5

 

 

 

(0.3

)

 

 

6.5

 

Amounts reclassified to Condensed Consolidated Statement of Income (a)

 

0.0

 

 

 

0.0

 

 

 

(2.3

)

 

 

(2.3

)

Tax benefit (expense)

 

0.0

 

 

 

(0.1

)

 

 

0.7

 

 

 

0.6

 

Other comprehensive income (loss)

 

6.3

 

 

 

0.4

 

 

 

(1.9

)

 

 

4.8

 

Balance at March 31, 2025

$

(46.9

)

 

$

4.8

 

 

$

16.0

 

 

$

(26.1

)

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2026

$

(31.3

)

 

$

4.8

 

 

$

6.6

 

 

$

(19.9

)

Other comprehensive income (loss) before reclassifications

 

(4.5

)

 

 

(0.5

)

 

 

10.8

 

 

 

5.8

 

Amounts reclassified to Condensed Consolidated Statement of Income (a)

 

0.0

 

 

 

0.0

 

 

 

0.3

 

 

 

0.3

 

Tax benefit (expense)

 

0.0

 

 

 

0.1

 

 

 

(2.9

)

 

 

(2.8

)

Other comprehensive income (loss)

 

(4.5

)

 

 

(0.4

)

 

 

8.2

 

 

 

3.3

 

Balance at March 31, 2026

$

(35.8

)

 

$

4.4

 

 

$

14.8

 

 

$

(16.6

)

 

(a)
Amounts reclassified to Cost of sales, SG&A expenses or interest expense.
v3.26.1
Commitments, Contingencies and Guarantees
 3 Months Ended
Mar. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments, Contingencies and Guarantees

17. Commitments, Contingencies and Guarantees

Commitments

a. The Company has a partnership with a supplier of raw materials that mines and processes sodium-based mineral deposits. The Company purchases the majority of its sodium-based raw material requirements from the partnership. The partnership agreement terminates upon two years’ written notice by either partner. Under the partnership agreement, the Company has an annual commitment to purchase 240,000 tons of sodium-based raw materials at the prevailing market price. The Company is not engaged in any other material transactions with the partnership or the partner supplier.

b. As of March 31, 2026, the Company had commitments of approximately $367.8. These commitments include the purchase of raw materials, packaging supplies and services from its vendors at market prices to enable the Company to respond quickly to changes in customer orders or requirements, as well as costs associated with licensing and promotion agreements.

c. As of March 31, 2026, the Company had various guarantees and letters of credit totaling $8.9.

d. In connection with the December 1, 2020 acquisition of the ZICAM® brand (the “Zicam Acquisition”), the Company deferred payment of $20.0 of the purchase price related to certain indemnifications provided by the seller. The Company made a cash payment of $12.9 in the first quarter of 2026 and a final payment of $2.0 in April 2026.

In connection with the December 24, 2021 acquisition of the THERABREATH® brand (the "TheraBreath Acquisition"), the Company deferred payment of $14.0 of the purchase price related to certain indemnity obligations provided by the seller. The deferred amount is payable in installments between two and four years from the closing, with the first installment payment of $2.0 paid in January 2024 and an additional $5.9 paid in the first quarter of 2025. The Company paid a final amount of $5.0 in January 2026.

In connection with the October 13, 2022 Hero Acquisition, the Company deferred payment of $8.0 of the purchase price to satisfy certain indemnification obligations. The amount, to the extent not used in satisfaction of such indemnity obligations, is payable five years from the closing.

In connection with the July 16, 2025 Touchland Acquisition, the business acquisition liability was contingent upon the achievement of certain 2025 net sales thresholds. The initial fair value of this business acquisition liability was $140.0, which was established in the initial

purchase price allocation. During 2025, the Company increased the fair value of the business acquisition liability to $158.7 based on updated 2025 net sales. The changes in fair value resulted in $18.7 of expense recorded within the Consumer Domestic segment. In April 2026, the Company paid $158.7 to satisfy the business acquisition liability. The Company deferred a payment of $5.0 of the purchase price to satisfy certain indemnification obligations. The additional amount, to the extent not used in satisfaction of such indemnity obligations, is payable three years from the closing.

 

Legal proceedings

e. In addition, in conjunction with the Company’s acquisition and divestiture activities, the Company entered into select guarantees and indemnifications of performance with respect to the fulfillment of the Company’s commitments under applicable purchase and sale agreements. The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract. Representations and warranties that survive the closing date generally survive for periods up to five years or the expiration of the applicable statutes of limitations. Potential losses under the indemnifications are generally limited to a portion of the original transaction price, or to other lesser specific dollar amounts for select provisions. With respect to sale transactions, the Company also routinely enters into non-competition agreements for varying periods of time. Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on the Company’s financial condition, results of operations and cash flows.

f. In addition to the matters described above, from time to time in the ordinary course of its business the Company is the subject of, or party to, various pending or threatened legal, regulatory or governmental actions or other proceedings, including, without limitation, those relating to, intellectual property, commercial transactions, product liability, purported consumer class actions, employment matters, antitrust, environmental, health, safety and other compliance related matters. Such proceedings are generally subject to considerable uncertainty and their outcomes, and any related damages, may not be reasonably predictable or estimable. Any such proceedings could result in a material adverse outcome negatively impacting the Company’s business, financial condition, results of operations or cash flows.
v3.26.1
Segments
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segments
18.
Segments

Segment Information

The Company operates three reportable segments: Consumer Domestic, Consumer International and Specialty Products Division. These segments are determined based on differences in the nature of products and organizational structure.

Segment revenues are derived from the sale of the following products:

Segment

 

 

Products

 

Consumer Domestic

 

Household and personal care products

Consumer International

 

Primarily personal care products

SPD

 

Specialty products

The Company also has equity in earnings of affiliates which is not reflected in a reportable segment. As of March 31, 2026, the Company held a 50% ownership interest in Armand. The Company’s equity in earnings of Armand totaled $2.3 and $1.6 for the three months ended March 31, 2026 and 2025.

Our reportable segments comprise the structure used by our Chief Executive Officer, who has been determined to be the Chief Operating Decision Maker (“CODM”) to make key operating decisions and assess performance. The CODM considers Operating

Income for evaluating performance of each segment and making decisions about allocating capital and other resources to each segment. Asset information and capital expenditures are not regularly provided to the CODM.

The following tables present financial information relating to the Company’s segments for the three months ended March 31, 2026 and 2025:

 

 

 

Three Months Ended March 31, 2026

 

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Consolidating Reclassification(1)

 

 

Total Consolidated

 

Net Sales

 

$

1,117.7

 

 

$

273.9

 

 

$

77.7

 

 

 

-

 

 

$

1,469.3

 

Cost of sales

 

 

578.2

 

 

 

143.2

 

 

 

48.6

 

 

 

17.9

 

 

 

787.9

 

Gross Profit

 

 

539.5

 

 

 

130.7

 

 

 

29.1

 

 

 

(17.9

)

 

 

681.4

 

Marketing expenses

 

 

104.2

 

 

 

34.6

 

 

 

0.6

 

 

 

-

 

 

 

139.4

 

Research and Development(2)

 

 

27.8

 

 

 

3.0

 

 

 

0.8

 

 

 

-

 

 

 

31.6

 

Selling, general and administrative expenses

 

 

167.3

 

 

 

53.2

 

 

 

16.8

 

 

 

(17.9

)

 

 

219.4

 

Income from Operations

 

 

240.2

 

 

 

39.9

 

 

 

10.9

 

 

 

-

 

 

 

291.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2025

 

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Consolidating Reclassification(1)

 

 

Total Consolidated

 

Net Sales

 

$

1,129.8

 

 

$

261.9

 

 

$

75.4

 

 

$

-

 

 

$

1,467.1

 

Cost of sales

 

 

597.4

 

 

 

147.3

 

 

 

46.4

 

 

 

16.4

 

 

 

807.5

 

Gross Profit

 

 

532.4

 

 

 

114.6

 

 

 

29.0

 

 

 

(16.4

)

 

 

659.6

 

Marketing expenses

 

 

107.7

 

 

 

28.0

 

 

 

0.9

 

 

 

-

 

 

 

136.6

 

Research and Development(2)

 

 

29.2

 

 

 

3.0

 

 

 

0.6

 

 

 

-

 

 

 

32.8

 

Selling, general and administrative expenses

 

 

150.7

 

 

 

45.9

 

 

 

14.7

 

 

 

(16.4

)

 

 

194.9

 

Income from Operations

 

 

244.8

 

 

 

37.7

 

 

 

12.8

 

 

 

-

 

 

 

295.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)
Reflects the administrative costs of the production planning and logistics functions which are elements of Cost of sales in the Company’s Consolidated Statements of Income but are allocated to the operating segments in SG&A expenses to determine operating segment income before income taxes.
(2)
All costs for Research & Development administration, global compliance, technology support, packaging and sustainability are reported in the Consumer Domestic segment.

Other segment expenses for the three months ended March 31, 2026 and 2025 include the following:

 

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Total Consolidated

 

Depreciation & Amortization

 

 

 

 

 

 

 

 

 

 

 

 

First Quarter of 2026

 

$

53.9

 

 

$

6.1

 

 

$

2.9

 

 

$

62.9

 

First Quarter of 2025

 

 

51.3

 

 

 

6.7

 

 

 

2.9

 

 

 

60.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product line revenues from external customers are as follows:

 

Three Months Ended

 

 

March 31,

 

 

March 31,

 

 

2026

 

 

2025

 

Household Products

$

641.6

 

 

$

614.9

 

Personal Care Products

 

476.1

 

 

 

514.9

 

Total Consumer Domestic

 

1,117.7

 

 

 

1,129.8

 

Total Consumer International

 

273.9

 

 

 

261.9

 

Total SPD

 

77.7

 

 

 

75.4

 

Total Consolidated Net Sales

$

1,469.3

 

 

$

1,467.1

 

 

Household Products include laundry, deodorizing and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin and hair care products, and cold and remedy products.

v3.26.1
Significant Accounting Policies (Policies)
 3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Recently Adopted Accounting Pronouncements

Recent Accounting Pronouncements Not Yet Adopted

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses and in January 2025, the FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date ("ASU 2025-01"). The ASU requires a public business entity to provide disaggregated disclosures of certain categories of expenses on an annual and interim basis including purchases of inventory, employee compensation, depreciation, and intangible asset amortization for each income statement line item that contains those expenses. ASU 2024-03, as clarified by ASU 2025-01, is effective for annual reporting periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027, with prospective or retrospective application permitted. The Company is currently evaluating the impact of adoption on the Company’s related disclosures.

There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.
v3.26.1
Inventories (Tables)
 3 Months Ended
Mar. 31, 2026
Inventory Disclosure [Abstract]  
Components of Inventories

Inventories consist of the following:

 

March 31,

 

 

December 31,

 

 

2026

 

 

2025

 

Raw materials and supplies

$

139.0

 

 

$

143.7

 

Work in process

 

24.0

 

 

 

35.0

 

Finished goods

 

415.4

 

 

 

356.1

 

Total

$

578.4

 

 

$

534.8

 
v3.26.1
Property, Plant and Equipment, Net ("PP&E") (Tables)
 3 Months Ended
Mar. 31, 2026
Property, Plant and Equipment [Abstract]  
Components of Property, Plant and Equipment

PP&E consists of the following:

 

March 31,

 

 

December 31,

 

 

2026

 

 

2025

 

Land

$

16.4

 

 

$

16.0

 

Buildings and improvements

 

368.6

 

 

 

367.5

 

Machinery and equipment

 

913.0

 

 

 

911.1

 

Software

 

139.2

 

 

 

138.9

 

Office equipment and other assets

 

131.4

 

 

 

131.6

 

Construction in progress

 

147.6

 

 

 

131.9

 

Gross PP&E

 

1,716.2

 

 

 

1,697.0

 

Less accumulated depreciation

 

892.3

 

 

 

874.2

 

Net PP&E

$

823.9

 

 

$

822.8

 

 

 

Three Months Ended

 

 

March 31,

 

 

March 31,

 

 

2026

 

 

2025

 

Depreciation expense on PP&E

$

21.6

 

 

$

22.6

 
v3.26.1
Earnings Per Share ("EPS") (Tables)
 3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Reconciliation Of Weighted Average Number Of Common Shares Outstanding

The following table sets forth a reconciliation of the weighted average number of shares of Common Stock outstanding to the weighted average number of shares outstanding on a diluted basis:

 

Three Months Ended

 

 

March 31,

 

 

March 31,

 

 

2026

 

 

2025

 

Weighted average common shares outstanding - basic

 

236.5

 

 

 

245.8

 

Dilutive effect of stock awards

 

1.6

 

 

 

2.2

 

Weighted average common shares outstanding - diluted

 

238.1

 

 

 

248.0

 

Antidilutive stock awards outstanding

 

3.1

 

 

 

2.1

 

 
v3.26.1
Stock Based Compensation Plans (Tables)
 3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Option Activity

The following table provides a summary of option activity:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

Weighted

 

 

Remaining

 

 

 

 

 

 

 

 

Average

 

 

Contractual

 

 

Aggregate

 

 

 

 

 

Exercise Price

 

 

Term

 

 

Intrinsic

 

 

Options

 

 

(per share)

 

 

(in Years)

 

 

Value

 

Outstanding at December 31, 2025

 

8.8

 

 

$

81.83

 

 

 

 

 

 

 

Granted

 

0.8

 

 

 

103.94

 

 

 

 

 

 

 

Exercised

 

(0.2

)

 

 

61.01

 

 

 

 

 

 

 

Outstanding at March 31, 2026

 

9.4

 

 

$

84.24

 

 

 

5.9

 

 

$

118.5

 

Exercisable at March 31, 2026

 

6.6

 

 

$

75.37

 

 

 

4.6

 

 

$

118.5

 
Information Regarding Intrinsic Value of Stock Options Exercised and Stock Compensation Expense Related to Stock Option Awards

The following table provides information regarding the intrinsic value of stock options exercised and stock compensation expense related to stock option awards:

 

 

Three Months Ended

 

 

March 31,

 

 

March 31,

 

 

2026

 

 

2025

 

Intrinsic Value of Stock Options Exercised

$

9.6

 

 

$

16.3

 

Stock Compensation Expense Related to Stock Option Awards

$

9.2

 

 

$

13.1

 

Issued Stock Options

 

0.8

 

 

 

1.0

 

Weighted Average Fair Value of Stock Options issued (per share)

$

28.75

 

 

 

33.43

 

Fair Value of Stock Options Issued

$

24.0

 

 

 

32.3

 
Assumptions Used in Valuation of Issued Stock Options

The following table provides a summary of the assumptions used in the valuation of issued stock options:

 

 

Three Months Ended

 

March 31,

 

March 31,

 

2026

 

2025

Risk-free interest rate

3.8%

 

4.2%

Expected life in years

6.7

 

7.0

Expected volatility

22.5%

 

22.6%

Dividend yield

1.2%

 

1.1%

 

 
Schedule of RSU Activity

The following table provides a summary of RSU activity:

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

Weighted

 

 

Remaining

 

 

 

 

 

 

 

 

Average Grant

 

 

Contractual

 

 

Aggregate

 

 

 

 

 

Date Fair Value

 

 

Term

 

 

Intrinsic

 

 

Shares

 

 

(per award)

 

 

(in Years)

 

 

Value

 

Outstanding at December 31, 2025

 

0.3

 

 

$

100.40

 

 

 

 

 

 

 

Granted

 

0.1

 

 

 

101.44

 

 

 

 

 

 

 

Vested

 

(0.1

)

 

 

97.41

 

 

 

 

 

 

 

Outstanding at March 31, 2026

 

0.3

 

 

$

101.77

 

 

 

9.2

 

 

$

27.6

 

Vested and expected to vest at March 31, 2026

 

0.3

 

 

$

101.77

 

 

 

9.2

 

 

$

27.6

 
Schedule Of PSU Activity

The following table provides a summary of PSU activity:

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

Weighted

 

 

Remaining

 

 

 

 

 

 

 

 

Average Grant

 

 

Contractual

 

 

Aggregate

 

 

 

 

 

Date Fair Value

 

 

Term

 

 

Intrinsic

 

 

Shares

 

 

(per award)

 

 

(in Years)

 

 

Value

 

Outstanding at December 31, 2025

 

0.1

 

 

$

106.52

 

 

 

 

 

 

 

Granted

 

0.6

 

 

 

95.03

 

 

 

 

 

 

 

Outstanding at March 31, 2026

 

0.7

 

 

$

96.64

 

 

 

9.8

 

 

$

59.8

 

Vested and expected to vest at March 31, 2026

 

0.7

 

 

$

96.64

 

 

 

9.8

 

 

$

59.8

 
v3.26.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Carrying Amounts and Estimated Fair Values of Other Financial Instruments

The following table presents the carrying amounts and estimated fair values of the Company’s other financial instruments at March 31, 2026 and December 31, 2025:

 

 

 

March 31, 2026

 

 

December 31, 2025

 

 

Input

 

Carrying

 

 

Fair

 

 

Carrying

 

 

Fair

 

 

Level

 

Amount

 

 

Value

 

 

Amount

 

 

Value

 

Financial Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

Level 1

 

$

291.8

 

 

$

291.8

 

 

$

217.5

 

 

$

217.5

 

Financial Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

3.15% Senior notes due August 1, 2027

Level 2

 

 

424.9

 

 

 

419.1

 

 

 

424.9

 

 

 

420.1

 

2.3% Senior notes due December 15, 2031

Level 2

 

 

399.5

 

 

 

354.6

 

 

 

399.5

 

 

 

355.4

 

5.6% Senior notes due November 15, 2032

Level 2

 

 

499.4

 

 

 

526.6

 

 

 

499.3

 

 

 

532.3

 

3.95% Senior notes due August 1, 2047

Level 2

 

 

397.9

 

 

 

313.2

 

 

 

397.9

 

 

 

318.4

 

5.00% Senior notes due June 15, 2052

Level 2

 

 

499.9

 

 

 

448.0

 

 

 

499.9

 

 

 

457.3

 
v3.26.1
Derivative Instruments and Risk Management (Tables)
 3 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Notional Amounts

The notional amount of a derivative instrument is the nominal or face amount used to calculate payments made on that instrument. Notional amounts are presented in the following table:

 

 

Notional

 

 

Notional

 

 

 

Amount

 

 

Amount

 

 

 

March 31, 2026

 

 

December 31, 2025

 

Derivatives designated as hedging instruments

 

 

 

 

 

 

Foreign exchange contracts

 

$

391.2

 

 

$

438.2

 

Diesel fuel contracts

 

3.4 gallons

 

 

4.5 gallons

 

Commodities contracts

 

54.8 pounds

 

 

43.6 pounds

 

Net Investment hedge

 

$

25.0

 

 

$

25.0

 

Derivatives not designated as hedging instruments

 

 

 

 

 

 

Foreign exchange contracts

 

$

9.1

 

 

$

2.4

 

Equity derivatives

 

$

13.0

 

 

$

12.0

 
v3.26.1
Acquisitions (Tables)
 3 Months Ended
Mar. 31, 2026
Business Acquisition [Line Items]  
Summary of Assets Acquired and Liabilities Assumed

The preliminary fair values of the net assets at acquisition are set forth as follows:

 

Accounts receivable

$

9.3

 

Inventory

 

25.8

 

Other current assets

 

1.3

 

Property, plant and equipment

 

5.5

 

Other long-term assets

 

2.1

 

Trade name

 

730.0

 

Customer relationship intangible asset

 

32.8

 

Goodwill

 

208.4

 

Accounts payable, accrued expenses and other liabilities

 

(23.3

)

Business acquisition liabilities - short-term

 

(141.9

)

Deferred income taxes

 

(183.8

)

Deferred and other long-term liabilities

 

(10.2

)

Cash purchase price at closing (net of cash acquired)

$

656.0

 
v3.26.1
Goodwill and Other Intangibles, Net (Tables)
 3 Months Ended
Mar. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Amortizable Intangible Assets

The following table provides information related to the carrying value of intangible assets with a useful life:

 

March 31, 2026

 

 

 

December 31, 2025

 

 

Gross

 

 

 

 

 

 

 

Amortization

 

Gross

 

 

 

 

 

 

 

 

 

 

 

Carrying

 

 

Accumulated

 

 

 

 

Period

 

Carrying

 

 

Accumulated

 

 

Impairment

 

 

 

 

 

Amount

 

 

Amortization

 

 

Net

 

(Years)

 

Amount

 

 

Amortization

 

 

Charges(1)

 

 

Net

 

Amortizable intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade Names

$

2,066.8

 

 

$

(551.8

)

 

$

1,515.0

 

3-20

 

$

2,113.4

 

 

$

(562.1

)

 

$

(11.6

)

 

$

1,539.7

 

Customer Relationships

 

573.3

 

 

 

(347.3

)

 

 

226.0

 

15-20

 

 

598.5

 

 

 

(365.2

)

 

 

(0.7

)

 

 

232.6

 

Patents/Formulas

 

200.7

 

 

 

(137.0

)

 

 

63.7

 

4-20

 

 

205.6

 

 

 

(139.2

)

 

 

0.0

 

 

 

66.4

 

Total

$

2,840.8

 

 

$

(1,036.1

)

 

$

1,804.7

 

 

 

$

2,917.5

 

 

$

(1,066.5

)

 

$

(12.3

)

 

$

1,838.7

 

 

(1) The $12.3 impairment charge relates to the Flawless trade name and Spinbrush customer relationship intangible asset, which had a gross value of $76.2 and accumulated amortization of $63.9 prior to full impairment. The impairments were a result of the Company's decision to exit these businesses.

Indefinite Lived Intangible Assets

The following table presents the carrying value of indefinite-lived intangible assets:

 

March 31,

 

 

December 31,

 

 

2026

 

 

2025

 

Gross Carrying Value Trade Names

$

1,672.5

 

 

$

1,680.7

 

Sale of Spinbrush Tradename

 

0.0

 

 

 

(7.9

)

Trade Names

$

1,672.5

 

 

$

1,672.8

 

 
Carrying Amount of Goodwill

The carrying amount of goodwill is as follows:

 

Consumer

 

 

Consumer

 

 

Specialty

 

 

 

 

 

Domestic

 

 

International

 

 

Products

 

 

Total

 

Balance at December 31, 2025

$

2,255.4

 

 

$

237.2

 

 

$

134.9

 

 

$

2,627.5

 

Touchland Acquisition adjustments

 

1.9

 

 

 

0.0

 

 

 

0.0

 

 

 

1.9

 

Balance at March 31, 2026

$

2,257.3

 

 

$

237.2

 

 

$

134.9

 

 

$

2,629.4

 

 
v3.26.1
Leases (Tables)
 3 Months Ended
Mar. 31, 2026
Leases [Abstract]  
Summary of Lease Information

A summary of the Company’s lease information is as follows:

 

 

March 31,

 

December 31,

 

 

Classification

2026

 

2025

 

Assets

 

 

 

 

 

Right of use assets

Other Assets

$

159.7

 

$

166.0

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

Current lease liabilities

Accrued Expenses and Other Liabilities

$

24.6

 

$

23.9

 

Long-term lease liabilities

Deferred and Other Long-term Liabilities

 

147.1

 

 

153.0

 

Total lease liabilities

 

$

171.7

 

$

176.9

 

 

 

 

 

 

 

Other information

 

 

 

 

 

Weighted-average remaining lease term (years)

 

 

7.3

 

 

7.4

 

Weighted-average discount rate

 

 

5.2

%

 

5.2

%

 

 

 

Three Months

 

 

Three Months

 

 

Ended

 

 

Ended

 

 

March 31, 2026

 

 

March 31, 2025

 

Statement of Income

 

 

 

 

 

Lease cost(1)

$

8.8

 

 

$

10.5

 

 

 

 

 

 

 

Other information

 

 

 

 

 

Leased assets obtained in exchange for new lease liabilities net of modifications

$

0.4

 

 

$

6.5

 

Cash paid for amounts included in the measurement of lease liabilities

$

7.7

 

 

$

10.5

 
(1)
Lease expense is included in Cost of sales or SG&A expenses based on the nature of the leased item. Short-term lease expense is excluded from this amount and is not material. The Company also has certain variable leases which are not material. The non-cash component of lease expense for the first three months of 2026 and 2025 was $6.5 and $8.1, respectively, and is included in the Amortization caption in the Condensed Consolidated Statement of Cash Flows.
Summary of Minimum Annual Rentals Including Reasonably Assured Renewal Options under Lease Agreements

The Company’s minimum annual rentals including reasonably assured renewal options under lease agreements are as follows:

 

 

Operating

 

 

 

Leases

 

2026

 

$

24.7

 

2027

 

 

30.9

 

2028

 

 

26.7

 

2029

 

 

26.1

 

2030

 

 

25.8

 

2031 and thereafter

 

 

73.6

 

Total future minimum lease commitments

 

 

207.8

 

Less: Imputed interest

 

 

(36.1

)

Present value of lease liabilities

 

$

171.7

 
v3.26.1
Accounts Payable, Accrued and Other Liabilities (Tables)
 3 Months Ended
Mar. 31, 2026
Payables and Accruals [Abstract]  
Accounts Payable, Accrued and Other Liabilities

Accounts payable, accrued expenses and other liabilities consist of the following:

 

March 31,

 

 

December 31,

 

 

2026

 

 

2025

 

Accounts payable

$

729.9

 

 

$

732.4

 

Accrued marketing and promotion costs

 

180.4

 

 

 

221.4

 

Accrued wages and related benefit costs

 

60.7

 

 

 

145.7

 

Other accrued current liabilities

 

408.8

 

 

 

394.8

 

Total

$

1,379.8

 

 

$

1,494.3

 
v3.26.1
Long-Term Debt (Tables)
 3 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Components of Short-Term Borrowings and Long-Term Debt

Long-term debt consists of the following:

 

March 31,

 

 

December 31,

 

 

2026

 

 

2025

 

 

 

 

 

 

 

Long-term debt

 

 

 

 

 

3.15% Senior notes due August 1, 2027

$

425.0

 

 

$

425.0

 

Less: Discount

 

(0.1

)

 

 

(0.1

)

2.3% Senior notes due December 15, 2031

 

400.0

 

 

 

400.0

 

Less: Discount

 

(0.5

)

 

 

(0.5

)

5.6% Senior notes due November 15, 2032

 

500.0

 

 

 

500.0

 

Less: Discount

 

(0.6

)

 

 

(0.7

)

3.95% Senior notes due August 1, 2047

 

400.0

 

 

 

400.0

 

Less: Discount

 

(2.1

)

 

 

(2.1

)

5.00% Senior notes due June 15, 2052

 

500.0

 

 

 

500.0

 

Less: Discount

 

(0.1

)

 

 

(0.1

)

Debt issuance costs, net

 

(15.9

)

 

 

(16.4

)

Total long-term debt

$

2,205.7

 

 

$

2,205.1

 
v3.26.1
Accumulated Other Comprehensive Income (Loss) (Tables)
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Components of Changes in Accumulated Other Comprehensive Income (Loss)

The components of changes in accumulated other comprehensive income (loss) are as follows:

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

Foreign

 

 

Defined

 

 

 

 

 

Other

 

 

Currency

 

 

Benefit

 

 

Derivative

 

 

Comprehensive

 

 

Adjustments

 

 

Plans

 

 

Agreements

 

 

Income (Loss)

 

Balance at January 1, 2025

$

(53.2

)

 

$

4.4

 

 

$

17.9

 

 

$

(30.9

)

Other comprehensive income (loss) before reclassifications

 

6.3

 

 

 

0.5

 

 

 

(0.3

)

 

 

6.5

 

Amounts reclassified to Condensed Consolidated Statement of Income (a)

 

0.0

 

 

 

0.0

 

 

 

(2.3

)

 

 

(2.3

)

Tax benefit (expense)

 

0.0

 

 

 

(0.1

)

 

 

0.7

 

 

 

0.6

 

Other comprehensive income (loss)

 

6.3

 

 

 

0.4

 

 

 

(1.9

)

 

 

4.8

 

Balance at March 31, 2025

$

(46.9

)

 

$

4.8

 

 

$

16.0

 

 

$

(26.1

)

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 1, 2026

$

(31.3

)

 

$

4.8

 

 

$

6.6

 

 

$

(19.9

)

Other comprehensive income (loss) before reclassifications

 

(4.5

)

 

 

(0.5

)

 

 

10.8

 

 

 

5.8

 

Amounts reclassified to Condensed Consolidated Statement of Income (a)

 

0.0

 

 

 

0.0

 

 

 

0.3

 

 

 

0.3

 

Tax benefit (expense)

 

0.0

 

 

 

0.1

 

 

 

(2.9

)

 

 

(2.8

)

Other comprehensive income (loss)

 

(4.5

)

 

 

(0.4

)

 

 

8.2

 

 

 

3.3

 

Balance at March 31, 2026

$

(35.8

)

 

$

4.4

 

 

$

14.8

 

 

$

(16.6

)

 

(a)
Amounts reclassified to Cost of sales, SG&A expenses or interest expense.
v3.26.1
Segments (Tables)
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Selected Financial Information Relating To Company's Segments

The following tables present financial information relating to the Company’s segments for the three months ended March 31, 2026 and 2025:

 

 

 

Three Months Ended March 31, 2026

 

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Consolidating Reclassification(1)

 

 

Total Consolidated

 

Net Sales

 

$

1,117.7

 

 

$

273.9

 

 

$

77.7

 

 

 

-

 

 

$

1,469.3

 

Cost of sales

 

 

578.2

 

 

 

143.2

 

 

 

48.6

 

 

 

17.9

 

 

 

787.9

 

Gross Profit

 

 

539.5

 

 

 

130.7

 

 

 

29.1

 

 

 

(17.9

)

 

 

681.4

 

Marketing expenses

 

 

104.2

 

 

 

34.6

 

 

 

0.6

 

 

 

-

 

 

 

139.4

 

Research and Development(2)

 

 

27.8

 

 

 

3.0

 

 

 

0.8

 

 

 

-

 

 

 

31.6

 

Selling, general and administrative expenses

 

 

167.3

 

 

 

53.2

 

 

 

16.8

 

 

 

(17.9

)

 

 

219.4

 

Income from Operations

 

 

240.2

 

 

 

39.9

 

 

 

10.9

 

 

 

-

 

 

 

291.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2025

 

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Consolidating Reclassification(1)

 

 

Total Consolidated

 

Net Sales

 

$

1,129.8

 

 

$

261.9

 

 

$

75.4

 

 

$

-

 

 

$

1,467.1

 

Cost of sales

 

 

597.4

 

 

 

147.3

 

 

 

46.4

 

 

 

16.4

 

 

 

807.5

 

Gross Profit

 

 

532.4

 

 

 

114.6

 

 

 

29.0

 

 

 

(16.4

)

 

 

659.6

 

Marketing expenses

 

 

107.7

 

 

 

28.0

 

 

 

0.9

 

 

 

-

 

 

 

136.6

 

Research and Development(2)

 

 

29.2

 

 

 

3.0

 

 

 

0.6

 

 

 

-

 

 

 

32.8

 

Selling, general and administrative expenses

 

 

150.7

 

 

 

45.9

 

 

 

14.7

 

 

 

(16.4

)

 

 

194.9

 

Income from Operations

 

 

244.8

 

 

 

37.7

 

 

 

12.8

 

 

 

-

 

 

 

295.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)
Reflects the administrative costs of the production planning and logistics functions which are elements of Cost of sales in the Company’s Consolidated Statements of Income but are allocated to the operating segments in SG&A expenses to determine operating segment income before income taxes.
(2)
All costs for Research & Development administration, global compliance, technology support, packaging and sustainability are reported in the Consumer Domestic segment.
Schedule of Other Segment Expenses

Other segment expenses for the three months ended March 31, 2026 and 2025 include the following:

 

 

 

Consumer Domestic

 

 

Consumer International

 

 

SPD

 

 

Total Consolidated

 

Depreciation & Amortization

 

 

 

 

 

 

 

 

 

 

 

 

First Quarter of 2026

 

$

53.9

 

 

$

6.1

 

 

$

2.9

 

 

$

62.9

 

First Quarter of 2025

 

 

51.3

 

 

 

6.7

 

 

 

2.9

 

 

 

60.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 
Product Line Revenues From External Customers

Product line revenues from external customers are as follows:

 

Three Months Ended

 

 

March 31,

 

 

March 31,

 

 

2026

 

 

2025

 

Household Products

$

641.6

 

 

$

614.9

 

Personal Care Products

 

476.1

 

 

 

514.9

 

Total Consumer Domestic

 

1,117.7

 

 

 

1,129.8

 

Total Consumer International

 

273.9

 

 

 

261.9

 

Total SPD

 

77.7

 

 

 

75.4

 

Total Consolidated Net Sales

$

1,469.3

 

 

$

1,467.1

 
v3.26.1
Basis of Presentation - Additional Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Research and development expenses $ 31.6 $ 32.8
v3.26.1
Inventories - Components of Inventories (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Inventory, Finished Goods and Work in Process, Net of Reserves [Abstract]    
Raw materials and supplies $ 139.0 $ 143.7
Work in process 24.0 35.0
Finished goods 415.4 356.1
Total $ 578.4 $ 534.8
v3.26.1
Property, Plant and Equipment, Net ("PP&E") - Components of Property, Plant and Equipment (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Property, Plant and Equipment [Line Items]    
Gross PP&E $ 1,716.2 $ 1,697.0
Less accumulated depreciation 892.3 874.2
Net PP&E 823.9 822.8
Land    
Property, Plant and Equipment [Line Items]    
Gross PP&E 16.4 16.0
Buildings and improvements    
Property, Plant and Equipment [Line Items]    
Gross PP&E 368.6 367.5
Machinery and equipment    
Property, Plant and Equipment [Line Items]    
Gross PP&E 913.0 911.1
Software    
Property, Plant and Equipment [Line Items]    
Gross PP&E 139.2 138.9
Office equipment and other assets    
Property, Plant and Equipment [Line Items]    
Gross PP&E 131.4 131.6
Construction in progress    
Property, Plant and Equipment [Line Items]    
Gross PP&E $ 147.6 $ 131.9
v3.26.1
Property, Plant and Equipment, Net ("PP&E") - Depreciation and Interest Charges on Property, Plant and Equipment (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Property, Plant and Equipment [Abstract]    
Depreciation expense on PP&E $ 21.6 $ 22.6
v3.26.1
Earnings Per Share ("EPS") - Reconciliation of Weighted Average Number of Shares of Common Stock Outstanding (Details) - shares
shares in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Earnings Per Share [Abstract]    
Weighted average common shares outstanding - basic 236.5 245.8
Dilutive effect of stock options 1.6 2.2
Weighted average common shares outstanding - diluted 238.1 248.0
Antidilutive stock options outstanding 3.1 2.1
v3.26.1
Stock Based Compensation Plans - Summary of Option Activity (Details)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2026
USD ($)
$ / shares
shares
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]  
Beginning Balance, Options | shares 8.8
Granted, Options | shares 0.8
Exercised, Options | shares (0.2)
Ending Balance, Options | shares 9.4
Exercisable at September 30, 2025 | shares 6.6
Beginning Balance, Weighted-Average Exercise Price | $ / shares $ 81.83
Granted, Weighted-Average Exercise Price | $ / shares 103.94
Exercised, Weighted-Average Exercise Price | $ / shares 61.01
Ending Balance, Weighted-Average Exercise Price | $ / shares 84.24
Exercisable at September 30, 2025 Weighted-Average Exercise Price | $ / shares $ 75.37
Outstanding at September 30, 2025, Weighted-Average Remaining Contractual Term, years 5 years 10 months 24 days
Exercisable at September 30, 2025, Weighted-Average Remaining Contractual Term, years 4 years 7 months 6 days
Outstanding at September 30, 2025, Aggregate Intrinsic Value | $ $ 118.5
Exercisable at September 30, 2025, Aggregate Intrinsic Value | $ $ 118.5
v3.26.1
Stock Based Compensation Plans - Schedule of Share Based Compensation Stock Options (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]    
Intrinsic Value of Stock Options Exercised $ 9.6 $ 16.3
Stock Compensation Expense Related to Stock Option Awards $ 9.2 $ 13.1
Issued Stock Options 0.8 1.0
Weighted Average Fair Value of Stock Options issued (per share) $ 28.75 $ 33.43
Fair Value of Stock Options Issued $ 24.0 $ 32.3
v3.26.1
Stock Based Compensation Plans - Assumptions Used in Valuation of Issued Stock Options (Details)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]    
Risk-free interest rate 3.80% 4.20%
Expected life in years 6 years 8 months 12 days 7 years
Expected volatility 22.50% 22.60%
Dividend yield 1.20% 1.10%
v3.26.1
Stock Based Compensation Plans (Additional Information) (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Common Stock, shares issued 293,709,982 293,709,982
Touchland Acquisition [Member]    
Restricted Stock or Unit Expense $ 6,300,000  
Touchland Acquisition [Member] | Common Stock [Member]    
Value of shares transferred in acquisition $ 50  
Vesting of stock in acquisitions 50.00%  
Restricted Stock Units (RSUs) [Member]    
Weighted Average Value, Granted $ 101.44  
Performance Stock Units (PSUs) [Member]    
Weighted Average Value, Granted $ 95.03  
Performance Stock Units (PSUs) [Member] | Maximum [Member]    
Performance stock issued range 200.00%  
Performance Stock Units (PSUs) [Member] | Minimum [Member]    
Performance stock issued range 0.00%  
Employee Stock Purchase Plan [Member]    
Shares Reserved For ESPP 750,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent 85.00%  
Maximum Value Purchased Under ESPP $ 25,000  
Employee Stock Purchase Plan [Member] | Minimum [Member]    
Shares Reserved For ESPP 728,031 660,582
v3.26.1
Share Repurchases - Additional Information (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Oct. 28, 2021
Accelerated Share Repurchases [Line Items]    
Stock repurchase program remaining authorized repurchase amount   $ 1,000.0
Commercial Bank    
Accelerated Share Repurchases [Line Items]    
Stock repurchase program remaining authorized repurchase amount $ 228.9  
v3.26.1
Stock Based Compensation Plans - Schedule Of Equity Instruments Other Than Options (Details)
 3 Months Ended
Mar. 31, 2026
$ / shares
shares
Restricted Stock Units  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Beginning Balance, December 31, 2025 | shares 0.3
Granted | shares 0.1
Vested | shares 0.1
Ending Balance, March 31, 2026 | shares 0.3
Vested and expected to vest at March 31, 2026 | shares 0.3
Beginning Balance, Weighted Average Grant $ 100.4
Weighted Average Value, Granted 101.44
Weighted Average, Vested 97.41
Weighted Average Grant, Ending Balance 101.77
Weighted average fair value, Vested and expected to vest $ 101.77
Weighted Average Remaining Contractual, Ending Balance 9 years 2 months 12 days
Weighted Average Remaining Contractual Term, Vested and expected to vest 9 years 2 months 12 days
Intrinsic Value, Ending Balance $ 27.6
Aggregate Intrinsic Value, Vested And Expected to Vest $ 27.6
Performance Stock Units  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Beginning Balance, December 31, 2025 | shares 0.1
Granted | shares 0.6
Ending Balance, March 31, 2026 | shares 0.7
Vested and expected to vest at March 31, 2026 | shares 0.7
Beginning Balance, Weighted Average Grant $ 106.52
Weighted Average Value, Granted 95.03
Weighted Average Grant, Ending Balance 96.64
Weighted average fair value, Vested and expected to vest $ 96.64
Weighted Average Remaining Contractual, Ending Balance 9 years 9 months 18 days
Weighted Average Remaining Contractual Term, Vested and expected to vest 9 years 9 months 18 days
Intrinsic Value, Ending Balance $ 59.8
Aggregate Intrinsic Value, Vested And Expected to Vest $ 59.8
v3.26.1
Fair Value Measurements - Carrying Amounts and Estimated Fair Values of Other Financial Instruments (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Senior notes, carrying amount $ 2,205.7 $ 2,205.1
Carrying Amount    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Cash equivalents, carrying amount 291.8 217.5
Fair Value | Fair Value, Inputs, Level 1    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Cash equivalents, fair value 291.8 217.5
3.15% Senior notes due August 1, 2027 | Carrying Amount    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Senior notes, carrying amount 424.9 424.9
3.15% Senior notes due August 1, 2027 | Fair Value | Fair Value, Inputs, Level 2    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Senior notes, fair value 419.1 420.1
2.3% Senior notes due December 15, 2031 | Carrying Amount    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Senior notes, carrying amount 399.5 399.5
2.3% Senior notes due December 15, 2031 | Fair Value | Fair Value, Inputs, Level 2    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Senior notes, fair value 354.6 355.4
5.6% Senior notes due November 15, 2032 | Carrying Amount    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Senior notes, carrying amount 499.4 499.3
5.6% Senior notes due November 15, 2032 | Fair Value | Fair Value, Inputs, Level 2    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Senior notes, fair value 526.6 532.3
3.95% Senior notes due August 1, 2047 | Carrying Amount    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Senior notes, carrying amount 397.9 397.9
3.95% Senior notes due August 1, 2047 | Fair Value | Fair Value, Inputs, Level 2    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Senior notes, fair value 313.2 318.4
5.00% Senior notes due June 15, 2052 | Carrying Amount    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Senior notes, carrying amount 499.9 499.9
5.00% Senior notes due June 15, 2052 | Fair Value | Fair Value, Inputs, Level 2    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Senior notes, fair value $ 448.0 $ 457.3
v3.26.1
Fair Value Measurements - Carrying Amounts and Estimated Fair Values of Other Financial Instruments (Parenthetical) (Details)
Mar. 31, 2026
Dec. 31, 2025
5.6% Senior notes due November 15, 2032    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Interest rate of debt 5.60% 5.60%
5.6% Senior notes due November 15, 2032 | Fair Value, Inputs, Level 2    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Interest rate of debt   5.60%
3.15% Senior notes due August 1, 2027    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Interest rate of debt 3.15% 3.15%
3.15% Senior notes due August 1, 2027 | Fair Value, Inputs, Level 2    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Interest rate of debt 3.15% 3.15%
2.3% Senior notes due December 15, 2031    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Interest rate of debt 2.30% 2.30%
2.3% Senior notes due December 15, 2031 | Fair Value, Inputs, Level 2    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Interest rate of debt 2.30% 2.30%
3.95% Senior notes due August 1, 2047    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Interest rate of debt 3.95% 3.95%
3.95% Senior notes due August 1, 2047 | Fair Value, Inputs, Level 2    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Interest rate of debt 3.95% 3.95%
5.00% Senior notes due June 15, 2052    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Interest rate of debt 5.00% 5.00%
5.00% Senior notes due June 15, 2052 | Fair Value, Inputs, Level 2    
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]    
Interest rate of debt 5.00% 5.00%
v3.26.1
Derivative Instruments and Risk Management - Schedule of Notional Amounts (Details)
gal in Millions, $ in Millions
Mar. 31, 2026
USD ($)
gal
Dec. 31, 2025
USD ($)
gal
Designated as Hedging Instrument | Foreign Exchange Contract    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivatives, Notional Amount $ 391.2 $ 438.2
Designated as Hedging Instrument | Diesel fuel contracts    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivatives, Notional Amount, Volume | gal 3.4 4.5
Designated as Hedging Instrument | Commodities Contracts    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivatives, Notional Amount, Volume | gal 54.8 43.6
Designated as Hedging Instrument | Net Investment Hedging    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivatives, Notional Amount $ 25.0 $ 25.0
Not Designated as Hedging Instrument | Foreign Exchange Contract    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivatives, Notional Amount 9.1 2.4
Not Designated as Hedging Instrument | Equity derivatives    
Derivative Instruments And Hedging Activities Disclosures [Line Items]    
Derivatives, Notional Amount $ 13.0 $ 12.0
v3.26.1
Acquisitions - Additional Information (Details) - USD ($)
 3 Months Ended 12 Months Ended
Jul. 16, 2025
Oct. 13, 2022
Dec. 24, 2021
Dec. 01, 2020
Dec. 01, 2020
May 01, 2019
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2024
Business Acquisition [Line Items]                  
Net Sales             $ 1,469,300,000 $ 1,467,100,000  
Maximum                  
Business Acquisition [Line Items]                  
Average life of the intangible assets, years           20 years      
Thera Breath Acquisition [Member]                  
Business Acquisition [Line Items]                  
Additional cash payment     $ 14,000,000            
Thera Breath Acquisition [Member] | Maximum                  
Business Acquisition [Line Items]                  
Business acquisition, period     4 years            
Thera Breath Acquisition [Member] | Minimum [Member]                  
Business Acquisition [Line Items]                  
Business acquisition, period     2 years            
Graphico                  
Business Acquisition [Line Items]                  
Average life of the intangible assets, years             20 years    
Zicam Acquisition [Member]                  
Business Acquisition [Line Items]                  
Additional cash payment         $ 20,000,000        
Zicam Acquisition [Member] | Maximum                  
Business Acquisition [Line Items]                  
Average life of the intangible assets, years       20 years          
Hero Acquisition [Member]                  
Business Acquisition [Line Items]                  
Additional cash payment   $ 8,000,000              
Business acquisition, period   5 years              
Touchland Acquisition [Member]                  
Business Acquisition [Line Items]                  
Closing payment of net of cash acquired $ 656,000,000           $ 656,000,000    
Additional cash payment 158,700,000           $ 5,000,000    
Acquisitions minority shares 50                
Net Sales                 $ 115,000,000
Shares trasferred in acquisition $ 50                
Percentage of Vesting Shares Acquired 50.00%                
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred $ 5,000,000                
v3.26.1
Acquisitions - Fair Values of Net Assets Acquired (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Jul. 16, 2025
Business Acquisition [Line Items]      
Goodwill $ 2,629.4 $ 2,627.5  
Touchland Acquisition      
Business Acquisition [Line Items]      
Accounts receivable 9.3    
Inventory 25.8    
Other current assets 1.3    
Property, plant and equipment 5.5    
Other long-term assets 2.1    
Trade name 730.0    
Customer relationship intangible asset 32.8    
Goodwill 208.4    
Accounts payable, accrued and other liabilities (23.3)    
Business acquisition liabilities - short-term (141.9)    
Deferred income taxes (183.8)    
Deferred and other long-term liabilities (10.2)    
Cash purchase price at closing (net of cash acquired) $ 656.0   $ 656.0
v3.26.1
Divestitures and Business Exits (Additional Information) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 09, 2025
May 01, 2025
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
TSA-related liability     $ 36.2 $ 0.0  
Flawless Business Exit [Member]          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Disposal Group Including Discontinued Operation Revenue         $ 29.3
Pre-tax loss on Divestiture   $ 17.6      
Disposal Group Including Discontinued Operation Costs Of Goods Sold   6.0      
Disposal Group, Including Discontinued Operation General and Administrative Expense   11.6      
Waterpik Showerheads Business Exit [Member]          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Disposal Group Including Discontinued Operation Revenue         35.5
Pre-tax loss on Divestiture   6.5      
Spinbrush Divestiture [Member]          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Disposal Group Including Discontinued Operation Revenue         $ 53.6
Pre-tax loss on Divestiture   21.2      
Disposal Group Including Discontinued Operation Costs Of Goods Sold   12.6      
Disposal Group, Including Discontinued Operation General and Administrative Expense   $ 8.6      
VMS Divestiture [Member]          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
TSA-related liability     $ 36.2    
Disposal of Property, Plant and Equipment $ 142.9        
Disposal of Inventory 54.0        
Disposal of Goodwill 12.6        
Disposal of other net assets 9.3        
Net cash proceeds $ 160.3        
Percentage of Consolidated Net Sales from Divested Vitamin Business 5.00%        
Pre-tax charge on Divestiture $ 58.5        
Post-tax charge of Divestiture       $ 45.6  
v3.26.1
Goodwill and Other Intangibles, Net - Indefinite Lived Intangible Assets (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Indefinite-lived Intangible Assets [Line Items]    
Trade Names $ 3,477.2 $ 3,511.5
Trade Names    
Indefinite-lived Intangible Assets [Line Items]    
Gross Carrying Amount, Trade names 1,672.5 1,680.7
Trade Names 1,672.5 1,672.8
Spinbrush impairment    
Indefinite-lived Intangible Assets [Line Items]    
Gross Carrying Amount, Trade names $ 0.0 $ 7.9
v3.26.1
Goodwill and Other Intangibles, Net - Amortizable Intangible Assets (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Mar. 31, 2026
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 2,917.5 $ 2,840.8
Accumulated Amortization (1,066.5) (1,036.1)
Impairment Charges [1] (12.3)  
Net 1,838.7 1,804.7
Trade Names    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 2,113.4 2,066.8
Accumulated Amortization (562.1) (551.8)
Impairment Charges [1] (11.6)  
Net 1,539.7 $ 1,515.0
Trade Names | Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Asset, Useful Life   3 years
Trade Names | Maximum    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Asset, Useful Life   20 years
Customer Relationships    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 598.5 $ 573.3
Accumulated Amortization (365.2) (347.3)
Impairment Charges [1] (0.7)  
Net 232.6 $ 226.0
Customer Relationships | Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Asset, Useful Life   15 years
Customer Relationships | Maximum    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Asset, Useful Life   20 years
Patents/Formulas    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 205.6 $ 200.7
Accumulated Amortization (139.2) (137.0)
Impairment Charges [1] 0.0  
Net $ 66.4 $ 63.7
Patents/Formulas | Minimum [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Asset, Useful Life   4 years
Patents/Formulas | Maximum    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Asset, Useful Life   20 years
[1] The $12.3 impairment charge relates to the Flawless trade name and Spinbrush customer relationship intangible asset, which had a gross value of $76.2 and accumulated amortization of $63.9 prior to full impairment. The impairments were a result of the Company's decision to exit these businesses.
v3.26.1
Goodwill and Other Intangibles, Net - Amortizable Intangible Assets (Parenthetical) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Finite-Lived Intangible Assets [Line Items]      
Impairment charges on assets $ 1.7 $ 1.4  
Accumulated Amortization (1,036.1)   $ (1,066.5)
Flawless trade name and Spinbrush customer relationship      
Finite-Lived Intangible Assets [Line Items]      
Impairment charges on assets 12.3    
Accumulated Amortization (63.9)    
Customer relationship intangible asset $ 76.2    
v3.26.1
Goodwill and Other Intangibles, Net - Carrying Amount of Goodwill (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2026
USD ($)
Goodwill [Line Items]  
Beginning balance $ 2,627.5
Touchland acquired goodwill 1.9
Ending balance 2,629.4
Consumer Domestic  
Goodwill [Line Items]  
Beginning balance 2,255.4
Touchland acquired goodwill 1.9
Ending balance 2,257.3
Consumer International  
Goodwill [Line Items]  
Beginning balance 237.2
Touchland acquired goodwill 0.0
Ending balance 237.2
Specialty Products  
Goodwill [Line Items]  
Beginning balance 134.9
Touchland acquired goodwill 0.0
Ending balance $ 134.9
v3.26.1
Goodwill and Other Intangibles, Net - Additional Information (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Oct. 01, 2025
May 01, 2025
Oct. 01, 2024
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]            
Amortization expense of intangible assets       $ 33.8 $ 29.3  
Estimated amortization expense, 2025       135.0    
Impairment charges on assets       1.7 1.4  
Other Assets, Noncurrent       343.0   $ 343.3
Fair Value Exceeded Carrying Value 117.00%   135.00%      
Property, Plant and Equipment, Net       823.9   822.8
Net Sales       1,469.3 1,467.1  
Cost of sales       787.9 807.5  
Selling, general and administrative expenses       251.0 $ 227.7  
Spinbrush Divestiture            
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]            
Disposal Group, Including Discontinued Operation General and Administrative Expense   $ 8.6        
Pre-tax loss on Divestiture   21.2        
Disposal Group Including Discontinued Operation Costs Of Goods Sold   $ 12.6        
Net Sales           $ 53.6
Trade Names            
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]            
Indefinite-Lived Trade Names $ 644.7          
Waterpik Member            
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]            
Discount on estimated future cashflow 8.00%          
EBITA margins 25.00%          
Maximum            
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]            
Estimated amortization expense, 2027       $ 134.0    
Maximum | Trade Names            
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]            
Finite-Lived Intangible Asset, Useful Life       20 years    
Minimum [Member]            
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]            
Estimated amortization expense, 2027       $ 120.0    
Minimum [Member] | Trade Names            
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]            
Finite-Lived Intangible Asset, Useful Life       3 years    
v3.26.1
Leases - Summary of Lease information (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Leases [Abstract]      
Right of use assets $ 159.7   $ 166.0
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Other Assets, Noncurrent   Other Assets, Noncurrent
Current lease liabilities $ 24.6   $ 23.9
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued expenses and other liabilities   Accrued expenses and other liabilities
Long-term lease liabilities $ 147.1   $ 153.0
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Other Liabilities, Noncurrent   Other Liabilities, Noncurrent
Total lease liabilities $ 171.7   $ 176.9
Weighted-average remaining lease term (years) 7 years 3 months 18 days   7 years 4 months 24 days
Weighted-average discount rate 5.20%   5.20%
Lease cost [1] $ 8.8 $ 10.5  
Leased assets obtained in exchange for new lease liabilities net of modifications 0.4 6.5  
Cash paid for amounts included in the measurement of lease liabilities $ 7.7 $ 10.5  
[1] Lease expense is included in Cost of sales or SG&A expenses based on the nature of the leased item. Short-term lease expense is excluded from this amount and is not material. The Company also has certain variable leases which are not material. The non-cash component of lease expense for the first three months of 2026 and 2025 was $6.5 and $8.1, respectively, and is included in the Amortization caption in the Condensed Consolidated Statement of Cash Flows.
v3.26.1
Leases - Summary of Minimum Annual Rentals Including Reasonably Assured Renewal Options under Lease Agreements (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Operating Leases    
2026 $ 24.7  
2027 30.9  
2028 26.7  
2029 26.1  
2030 25.8  
2031 and thereafter 73.6  
Total future minimum lease commitments 207.8  
Less: Imputed interest (36.1)  
Present value of lease liabilities $ 171.7 $ 176.9
v3.26.1
Accounts Payable, Accrued and Other Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Accounts Payable and Accrued Liabilities, Current [Abstract]    
Accounts payable $ 729.9 $ 732.4
Accrued marketing and promotion costs 180.4 221.4
Accrued wages and related benefit costs 60.7 145.7
Other accrued current liabilities 408.8 394.8
Total $ 1,379.8 $ 1,494.3
v3.26.1
Accounts Payable, Accrued Expenses and Other Liabilities (Additional Information) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Payables and Accruals [Abstract]      
Supply Chain Finance Program Outstanding Obligations $ 115.9   $ 84.7
Supply Chain Financing payments included in operating activities within the Company's Consolidated Statements of Cash Flows $ 108.1 $ 106.5  
v3.26.1
Long-Term Debt - Summary of Long-Term Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Long-term debt    
Debt issuance costs, net $ (15.9) $ (16.4)
Total long-term debt 2,205.7 2,205.1
Net long-term debt 2,205.7 2,205.1
3.15% Senior notes due August 1, 2027    
Long-term debt    
Senior notes 425.0 425.0
Less: Discount (0.1) (0.1)
2.3% Senior notes due December 15, 2031    
Long-term debt    
Senior notes 400.0 400.0
Less: Discount (0.5) (0.5)
5.6% Senior notes due November 15, 2032    
Long-term debt    
Senior notes 500.0 500.0
Less: Discount (0.6) (0.7)
3.95% Senior notes due August 1, 2047    
Long-term debt    
Senior notes 400.0 400.0
Less: Discount (2.1) (2.1)
5.00% Senior notes due June 15, 2052    
Long-term debt    
Senior notes 500.0 500.0
Less: Discount $ (0.1) $ (0.1)
v3.26.1
Long-Term Debt - Summary of Short-Term Borrowings and Long-Term Debt (Parenthetical) (Details)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
3.15% Senior notes due August 1, 2027    
Debt Instrument [Line Items]    
Interest rate of debt 3.15% 3.15%
Maturity date of debt Aug. 01, 2027 Aug. 01, 2027
2.3% Senior notes due December 15, 2031    
Debt Instrument [Line Items]    
Interest rate of debt 2.30% 2.30%
Maturity date of debt Dec. 15, 2031 Dec. 15, 2031
5.6% Senior notes due November 15, 2032    
Debt Instrument [Line Items]    
Interest rate of debt 5.60% 5.60%
Maturity date of debt Nov. 15, 2032 Nov. 15, 2032
3.95% Senior notes due August 1, 2047    
Debt Instrument [Line Items]    
Interest rate of debt 3.95% 3.95%
Maturity date of debt Aug. 01, 2047 Aug. 01, 2047
5.00% Senior notes due June 15, 2052    
Debt Instrument [Line Items]    
Interest rate of debt 5.00% 5.00%
Maturity date of debt Jun. 15, 2052 Jun. 15, 2052
v3.26.1
Long-Term Debt (Additional Information) (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Debt Instrument [Line Items]    
Aggregate commitments $ 367.8  
5.00% Senior notes due June 15, 2052    
Debt Instrument [Line Items]    
Maturity date of debt Jun. 15, 2052 Jun. 15, 2052
Senior Notes $ 500.0 $ 500.0
Debt Instrument, Interest Rate, Stated Percentage 5.00% 5.00%
v3.26.1
Accumulated Other Comprehensive Income (Loss) - Components of Changes in Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Accumulated Other Comprehensive Income Loss [Line Items]    
Beginning balance $ (19.9) $ (30.9)
Other comprehensive income (loss) before reclassifications 5.8 6.5
Amounts reclassified to Condensed Consolidated Statement of Income [1] 0.3 (2.3)
Tax benefit (expense) (2.8) 0.6
Other comprehensive income (loss) 3.3 4.8
Ending balance (16.6) (26.1)
Foreign Currency Adjustments    
Accumulated Other Comprehensive Income Loss [Line Items]    
Beginning balance (31.3) (53.2)
Other comprehensive income (loss) before reclassifications 4.5 6.3
Amounts reclassified to Condensed Consolidated Statement of Income [1] 0.0 0.0
Tax benefit (expense) 0.0 0.0
Other comprehensive income (loss) 4.5 6.3
Ending balance (35.8) (46.9)
Defined Benefit Plans    
Accumulated Other Comprehensive Income Loss [Line Items]    
Beginning balance 4.8 4.4
Other comprehensive income (loss) before reclassifications 0.5 (0.5)
Amounts reclassified to Condensed Consolidated Statement of Income [1] 0.0 0.0
Tax benefit (expense) 0.1 (0.1)
Other comprehensive income (loss) 0.4 (0.4)
Ending balance 4.4 4.8
Derivative Agreements    
Accumulated Other Comprehensive Income Loss [Line Items]    
Beginning balance 6.6 17.9
Other comprehensive income (loss) before reclassifications (10.8) (0.3)
Amounts reclassified to Condensed Consolidated Statement of Income [1] 0.3 (2.3)
Tax benefit (expense) (2.9) 0.7
Other comprehensive income (loss) (8.2) 1.9
Ending balance $ 14.8 $ 16.0
[1] Amounts reclassified to Cost of sales, SG&A expenses or interest expense.
v3.26.1
Commitments, Contingencies and Guarantees - Additional Information (Details)
$ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Jul. 16, 2025
USD ($)
Oct. 13, 2022
USD ($)
Dec. 24, 2021
USD ($)
Dec. 01, 2020
USD ($)
Jan. 31, 2026
USD ($)
Mar. 31, 2026
USD ($)
Tons
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
Jan. 31, 2024
USD ($)
Commitments And Contingencies Disclosure [Line Items]                  
Annual purchase commitment, in tons | Tons           240,000      
Aggregate commitments           $ 367.8      
Outstanding guarantees and letters of credit           8.9      
Zicam Acquisition [Member]                  
Commitments And Contingencies Disclosure [Line Items]                  
Business Acquisition Additional Cash Payable First Installment           12.9      
Additional cash payment       $ 20.0          
Business acquisition remaining cash payable installment           2.0      
Hero Acquisition [Member]                  
Commitments And Contingencies Disclosure [Line Items]                  
Additional cash payment   $ 8.0              
Business acquisition, period   5 years              
Thera Breath Acquisition [Member]                  
Commitments And Contingencies Disclosure [Line Items]                  
Business Acquisition Additional Cash Payable First Installment                 $ 2.0
Additional cash payment     $ 14.0            
Business acquisition additional cash payable second installment             $ 5.9    
Business acquisition remaining cash payable installment         $ 5.0        
Touchland Acquisition [Member]                  
Commitments And Contingencies Disclosure [Line Items]                  
Additional cash payment $ 158.7         5.0      
Business Combination, Contingency Recognized at Acquisition Date, Liability Assumed, Fair Value $ 140.0                
Increased in Fair Value of the Business Acquisition Liability               $ 158.7  
Changes in fair value expense               $ 18.7  
Business acquisition liability paid           $ 158.7      
Minimum | Thera Breath Acquisition [Member]                  
Commitments And Contingencies Disclosure [Line Items]                  
Business acquisition, period     2 years            
Maximum | Thera Breath Acquisition [Member]                  
Commitments And Contingencies Disclosure [Line Items]                  
Business acquisition, period     4 years            
v3.26.1
Related Party Transactions - Additional Information (Details)
Mar. 31, 2026
Armand Products Company  
Related Party Transaction [Line Items]  
Percentage of ownership interest 50.00%
v3.26.1
Segments - Additional Information (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2026
USD ($)
Segment
Mar. 31, 2025
USD ($)
Segment Reporting Information [Line Items]    
Number of reportable segments | Segment 3  
Equity in earnings of affiliates $ 2.3 $ 1.6
Revenue from Contract with Customer, Excluding Assessed Tax $ 1,469.3 1,467.1
Armand Products Company    
Segment Reporting Information [Line Items]    
Percentage of ownership interest 50.00%  
Armand Products Company and ArmaKleen Company    
Segment Reporting Information [Line Items]    
Equity in earnings of affiliates $ 2.3 $ 1.6
v3.26.1
Segments - Selected Financial Information Relating To Company's Segments (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]    
Net Sales $ 1,469.3 $ 1,467.1
Cost of sales 787.9 807.5
Gross Profit 681.4 659.6
Marketing expenses 139.4 136.6
Research and Development 31.6 32.8
Selling, general and administrative expenses 251.0 227.7
Income from Operations 291.0 295.3
Operating Segments    
Segment Reporting Information [Line Items]    
Net Sales 1,469.3 1,467.1
Cost of sales 787.9 807.5
Gross Profit 681.4 659.6
Marketing expenses 139.4 136.6
Research and Development [1] 31.6 32.8
Selling, general and administrative expenses 219.4 194.9
Income from Operations 291.0 295.3
Operating Segments | Consumer Domestic    
Segment Reporting Information [Line Items]    
Net Sales 1,117.7 1,129.8
Cost of sales 578.2 597.4
Gross Profit 539.5 532.4
Marketing expenses 104.2 107.7
Research and Development [1] 27.8 29.2
Selling, general and administrative expenses 167.3 150.7
Income from Operations 240.2 244.8
Operating Segments | Consumer International    
Segment Reporting Information [Line Items]    
Net Sales 273.9 261.9
Cost of sales 143.2 147.3
Gross Profit 130.7 114.6
Marketing expenses 34.6 28.0
Research and Development [1] 3.0 3.0
Selling, general and administrative expenses 53.2 45.9
Income from Operations 39.9 37.7
Operating Segments | Specialty Products    
Segment Reporting Information [Line Items]    
Net Sales 77.7 75.4
Cost of sales 48.6 46.4
Gross Profit 29.1 29.0
Marketing expenses 0.6 0.9
Research and Development [1] 0.8 0.6
Selling, general and administrative expenses 16.8 14.7
Income from Operations 10.9 12.8
Operating Segments | Consolidating Reclassification    
Segment Reporting Information [Line Items]    
Net Sales [2] 0.0 0.0
Cost of sales [2] 17.9 16.4
Gross Profit [2] (17.9) (16.4)
Marketing expenses [2] 0.0 0.0
Research and Development [1],[2] 0.0 0.0
Selling, general and administrative expenses [2] (17.9) (16.4)
Income from Operations [2] $ 0.0 $ 0.0
[1] All costs for Research & Development administration, global compliance, technology support, packaging and sustainability are reported in the Consumer Domestic segment.
[2] Reflects the administrative costs of the production planning and logistics functions which are elements of Cost of sales in the Company’s Consolidated Statements of Income but are allocated to the operating segments in SG&A expenses to determine operating segment income before income taxes.
v3.26.1
Segments - Selected Financial Information Relating To Company's Segments (Parenthetical) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]    
Net Sales $ 1,469.3 $ 1,467.1
v3.26.1
Segments - Schedule of Other Segment Expenses (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]    
Depreciation, Depletion and Amortization, Total $ 62.9 $ 60.9
Operating Segments | Consumer Domestic    
Segment Reporting Information [Line Items]    
Depreciation, Depletion and Amortization, Total 53.9 51.3
Operating Segments | Consumer International    
Segment Reporting Information [Line Items]    
Depreciation, Depletion and Amortization, Total 6.1 6.7
Operating Segments | Specialty Products    
Segment Reporting Information [Line Items]    
Depreciation, Depletion and Amortization, Total $ 2.9 $ 2.9
v3.26.1
Segments - Product Line Revenues from External Customers (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information [Line Items]    
Net Sales $ 1,469.3 $ 1,467.1
Operating Segments    
Segment Reporting Information [Line Items]    
Net Sales 1,469.3 1,467.1
Operating Segments | Consumer Domestic    
Segment Reporting Information [Line Items]    
Net Sales 1,117.7 1,129.8
Operating Segments | Consumer Domestic | Household Products    
Segment Reporting Information [Line Items]    
Net Sales 641.6 614.9
Operating Segments | Consumer Domestic | Personal Care Products    
Segment Reporting Information [Line Items]    
Net Sales 476.1 514.9
Operating Segments | Consumer International    
Segment Reporting Information [Line Items]    
Net Sales 273.9 261.9
Operating Segments | Specialty Products    
Segment Reporting Information [Line Items]    
Net Sales $ 77.7 $ 75.4
v3.26.1
Subsequent Events (Additional Information) (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Subsequent Event [Line Items]    
Common stock valued $ 293.7 $ 293.7